Skip to main content
U.S. flag
Health and Human Services Logo

An official website of the Department of Health & Human Services

menu-iconMore mobile-close-icon
mobile-back-btn-icon Back
  • menu-iconMenu
  • mobile-search-icon
AHRQ: Agency for Healthcare Research and Quality
  • Search All AHRQ Sites
  • Careers
  • Contact Us
  • Español
  • FAQs
  • Email Updates
MEPS Home Medical Expenditure Panel Survey
Font Size:
Contact MEPS FAQ Site Map  
S
M
L
XL
 

MEPS HC 241: 2022 Medical Conditions

August 2024

Agency for Healthcare Research and Quality
Center for Financing, Access, and Cost Trends
5600 Fishers Lane
Rockville, MD 20857
(301) 427-1406

Table of Contents

A. Data Use Agreement
B. Background
1.0 Household Component
2.0 Medical Provider Component
3.0 Survey Management and Data Collection
C. Technical and Programming Information
1.0 General Information
2.0 Data File Information
2.1 Codebook Structure
2.2 Reserved Codes
2.3 Codebook Format
2.4 Variable Naming
2.5 File Contents
2.5.1 Identifier Variables (DUID-CONDRN)
2.5.2 Medical Condition Variables (AGEDIAG-ICD10CDX)
2.5.3 Utilization Variables (OBCOND - RXCOND)
3.0 Survey Sample Information
3.1 Discussion of Pandemic Effects on Quality of MEPS Data
3.2 Sample Weight (PERWT22F)
3.3 Details on Person Weight Construction
3.3.1 MEPS Panel 24 Weight Development Process
3.3.2 MEPS Panel 26 Weight Development Process
3.3.3 MEPS Panel 27 Weight Development Process
3.3.4 The Final Weight for 2022
3.4 Coverage
3.5 Using MEPS Data for Trend Analysis
4.0 National Health Interview Survey (NHIS)
5.0 Longitudinal Analysis
References
D. Variable-Source Crosswalk
Appendix Page
1 ICD10CDX and CCSR Condition Code Frequencies

A. Data Use Agreement

Individual identifiers have been removed from the micro-data contained in these files. Nevertheless, under Sections 308 (d) and 903 (c) of the Public Health Service Act (42 U.S.C. 242m and 42 U.S.C. 299 a-1), data collected by the Agency for Healthcare Research and Quality (AHRQ) and/or the National Center for Health Statistics (NCHS) may not be used for any purpose other than for the purpose for which they were supplied; any effort to determine the identity of any reported cases is prohibited by law.

Therefore in accordance with the above referenced Federal Statute, it is understood that:

  1. No one is to use the data in this dataset in any way except for statistical reporting and analysis; and

  2. If the identity of any person or establishment should be discovered inadvertently, then (a) no use will be made of this knowledge, (b) the Director Office of Management AHRQ will be advised of this incident, (c) the information that would identify any individual or establishment will be safeguarded or destroyed, as requested by AHRQ, and (d) no one else will be informed of the discovered identity; and

  3. No one will attempt to link this dataset with individually identifiable records from any datasets other than the Medical Expenditure Panel Survey or the National Health Interview Survey. Furthermore, linkage of the Medical Expenditure Panel Survey and the National Health Interview Survey may not occur outside the AHRQ Data Center, NCHS Research Data Center (RDC) or the U.S. Census RDC network.

By using these data you signify your agreement to comply with the above stated statutorily based requirements with the knowledge that deliberately making a false statement in any matter within the jurisdiction of any department or agency of the Federal Government violates Title 18 part 1 Chapter 47 Section 1001 and is punishable by a fine of up to $10,000 or up to 5 years in prison.

The Agency for Healthcare Research and Quality requests that users cite AHRQ and the Medical Expenditure Panel Survey as the data source in any publications or research based upon these data.

Return To Table Of Contents

B. Background

1.0 Household Component

The Medical Expenditure Panel Survey (MEPS) provides nationally representative estimates of health care use, expenditures, sources of payment, and health insurance coverage for the U.S. civilian noninstitutionalized population. The MEPS Household Component (HC) also provides estimates of respondents’ health status, demographic and socioeconomic characteristics, employment, access to care, and satisfaction with care. Estimates can be produced for individuals, families, and selected population subgroups. The panel design of the survey includes five rounds of interviews covering 2 full calendar years. Additional rounds were added to Panel 24 in 2021 and 2022, covering the third and fourth years, respectively, to compensate for the smaller number of completed interviews in later panels. These extra rounds provide data for examining person-level changes in selected variables such as expenditures, health insurance coverage, and health status. Information about each household member is collected through computer-assisted personal interviewing (CAPI) technology, and the survey builds on this information from interview to interview. All data for a sampled household are reported by a single household respondent.

The MEPS HC was initiated in 1996. Each year, a new panel of sample households is selected. Because the data collected are comparable to those from earlier medical expenditure surveys conducted in 1977 and 1987, it is possible to analyze long-term trends. Historically, each annual MEPS HC sample consists of approximately up to 15,000 households. Data can be analyzed at the person, the family, or the event level. Data must be weighted to produce national estimates.

The set of households selected for each panel of the MEPS HC is a subsample of households participating in the previous year’s National Health Interview Survey (NHIS) conducted by the National Center for Health Statistics (NCHS). The NHIS sampling frame provides a nationally representative sample of the U.S. civilian noninstitutionalized population. In 2006, the NCHS implemented a new sample design for the NHIS, to include households with Asian persons in addition to households with Black and Hispanic persons in the oversampling of minority populations. In 2016, NCHS introduced another sample design that discontinued the oversampling of these minority groups.

Return To Table Of Contents

2.0 Medical Provider Component

When the household CAPI interview is completed, and permission is obtained from the household survey respondents to contact their medical provider(s), a sample of these providers is contacted by telephone to obtain information that household respondents cannot accurately provide. This part of the MEPS is called the Medical Provider Component (MPC), and it collects information on dates of visits, diagnosis and procedure codes, and charges and payments. The Pharmacy Component (PC), a subcomponent of the MPC, does not collect data on charges or on diagnosis and procedure codes, but it does collect detailed information on drugs, including the National Drug Code (NDC) and medicine name, as well as amounts of payment. The MPC is not designed to yield national estimates. It is primarily used as an imputation source to supplement/replace household reported expenditure information.

Return To Table Of Contents

3.0 Survey Management and Data Collection

MEPS HC and MPC data are collected under the authority of the Public Health Service Act. The MEPS HC data are collected under contract with Westat, Inc. and the MEPS MPC data are collected under contract with Research Triangle Institute. Datasets and summary statistics are edited and published in accordance with the confidentiality provisions of the Public Health Service Act and the Privacy Act. The NCHS provides consultation and technical assistance.

As soon as the MEPS data are collected and edited, they are released to the public in stages of microdata files and tables via the MEPS website and datatools.ahrq.gov.

Additional information on MEPS is available from the MEPS project manager or the MEPS public use data manager at the Center for Financing, Access, and Cost Trends, Agency for Healthcare Research and Quality, 5600 Fishers Lane, Rockville, MD 20857 (301-427-1406).

Return To Table Of Contents

C. Technical and Programming Information

1.0 General Information

This documentation describes the Medical Conditions Public Use File HC 241 (hereafter referred to as the Conditions PUF), which is one in a series of public use data files to be released from the 2022 Medical Expenditure Panel Survey Household Component (MEPS HC). It was released as an ASCII file (with related SAS, SPSS, R, and Stata programming statements and data user information), and as a SAS dataset, a SAS transport file, a Stata dataset, and an Excel file. The Conditions PUF provides information on household-reported medical conditions collected from a nationally representative sample of the U.S. civilian noninstitutionalized population for calendar year 2022 MEPS HC. It contains 33 variables and has a logical record length of 119 with an additional 2-byte carriage return/line feed at the end of each record.

This documentation offers a brief overview of the types and levels of data provided and a detailed description of the content and structure of the files. It is organized into the following sections:

  • Data File Information (Section 2.0)

  • Survey Sample Information (Section 3.0)

  • National Health Interview Survey (Section 4.0)

  • Longitudinal Analysis (Section 5.0)

  • Variable-Source Crosswalk (Section D)

  • Appendix: ICD10CDX and CCSR Condition Code Frequencies (Appendix 1)

A codebook of all the variables included in the 2022 Conditions PUF is provided in an accompanying file.

For more information on the MEPS sample design, see Chowdhury et al. (2019). A copy of the survey instrument used to collect the information in this PUF is available on the MEPS website.

Return To Table Of Contents

2.0 Data File Information

This PUF contains 83,173 records. Each record represents one current medical condition reported for a household survey member who resides in an eligible responding household and who has a positive person or family weight. A condition is defined as current if it is linked to an event during 2022. Conditions in the Priority Condition Enumeration (PE) section are asked in the context of “has (person) ever been told by a doctor or other health care professional that they have (condition)?” except joint pain and chronic bronchitis, which asks only about the last 12 months. Persons with a response of Yes (1) to a priority condition question for whom the condition is not current as defined above will not have a record for that condition in this PUF.

This PUF consists of MEPS survey data obtained in Rounds 7, 8, and 9 of Panel 24; Rounds 3, 4, and 5 of Panel 26; and Rounds 1, 2, and 3 of Panel 27, the rounds for the MEPS panels covering calendar year 2022. Panel 24 was extended to include Rounds 7, 8, and 9, and the Panel 24 Round 7 reference period was extended into 2022.

For most variables on the file, the codebook provides both weighted and unweighted frequencies. The exceptions to this are weight variables and variance estimation variables. Only unweighted frequencies of these variables are included in the accompanying codebook file. See the Weights Variables list in Section D, “Variable-Source Crosswalk.”

Person-level data (e.g., demographic or health insurance characteristics) from the 2022 MEPS Full Year Consolidated file (HC 243) can be merged to the records in this file using DUPERSID. Since each record represents a single condition reported by a household respondent, some household members may have multiple medical conditions and thus will be represented by multiple records on this file. Other household members may have had no reported medical conditions and thus will have no records on this file. Still other household members may have had a reported medical condition that did not meet the criteria above and thus will have no records on this file. Data from this file also can be merged to 2022 MEPS Event Files (HC 239A, and HC 239D through HC 239H) by using the link files provided in HC 239I. (See HC 239I documentation for details.)

Return To Table Of Contents

2.1 Codebook Structure

The codebook and data file list variables in the following order:

  • Unique person identifiers

  • Unique condition identifiers

  • Medical condition variables

  • Utilization variables

  • Weight and variance estimation variables

Note that the person identifier is unique within this data year.

Return To Table Of Contents

2.2 Reserved Codes

This Conditions PUF contains several reserved code values.

Table 1
Reserved Code Values and Definitions

Value Definition
-1 Inapplicable Question was not asked due to skip pattern
-7 Refused Question was asked and respondent refused to answer question
-8 Don’t Know Question was asked and respondent did not know answer or the information could not be ascertained
-15 Cannot be Computed Value cannot be derived from data

The value Cannot be Computed (-15) was assigned to the MEPS constructed variables when there was not enough information from the instrument to calculate the constructed variables. Not having enough information is often the result of skip patterns in the data or of missing information stemming from the responses of Refused (-7) or Don’t Know (-8). Note that, in addition to Don’t Know, reserved code -8 also includes cases for which the information from the question was Not Ascertained.

Return To Table Of Contents

2.3 Codebook Format

This codebook describes an ASCII dataset (although the data are also being provided in an Excel file, a Stata dataset, a SAS dataset, and a SAS transport file), and provides the programming identifiers for each variable.

Table 2
Variable Programming Identifiers

Identifier Description
Name Variable name
Description Variable descriptor
Format Number of bytes
Type Type of data: numeric (indicated by NUM) or character (indicated by CHAR)
Start Beginning column position of variable in record
End Ending column position of variable in record

Return To Table Of Contents

2.4 Variable Naming

In general, the variable names reflect the content of the variable, with an 8-character limitation. Edited variables end in an “X” and are so noted in the variable label. (CONDIDX, which is an encrypted identifier variable, also ends in an “X”.)

As the collection, universe, or categories of variables were altered, the variable names have been appended with “_Myy” to indicate the collection year in which the alterations took place. These alterations are described in detail throughout this document.

Variables in this Conditions PUF were derived either from the questionnaire itself or from the CAPI. The source of each variable is identified in Section D: “Variable-Source Crosswalk.” Sources for each variable are indicated in one of three ways: (1) variables derived from CAPI or assigned in sampling are so indicated; (2) variables collected at one or more specific questions have those numbers and questionnaire sections indicated in the “Source” column; and (3) variables constructed from multiple questions using complex algorithms are labeled “Constructed” in the “Source” column.

Return To Table Of Contents

2.5 File Contents

2.5.1 Identifier Variables (DUID-CONDRN)

The definitions of Dwelling Units (DUs) in the MEPS HC are generally consistent with the definitions employed for the NHIS. The Dwelling Unit ID (DUID) is a 7-digit ID number consisting of a 2-digit panel number followed by a 5-digit random number assigned after the case was sampled for MEPS. A 3-digit person number (PID) uniquely identifies each person within the DU. The variable DUPERSID is the combination of the variables DUID and PID. IDs begin with a 2-digit panel number.

CONDN is the condition number and uniquely identifies each condition reported for an individual. A 3-digit CONDN beginning with “9” reflects a condition that was added during the editing process. Note that conditions are not added every year during editing. The range in this PUF for CONDN is 1-70.

The variable CONDIDX uniquely identifies each condition (i.e., each record in this PUF) and is the combination of DUPERSID and CONDN. CONDIDX has a length of 13 with DUPERSID (10) and CONDN (3) combined.

PANEL is a constructed variable used to specify the panel number for the interview in which the condition was reported. PANEL will indicate Panel 24, Panel 26, or Panel 27. The panel number is included as the first two digits of the DUID and DUPERSID.

CONDRN indicates the round in which the condition was first reported. For a small number of cases, conditions that actually began in an earlier round were not reported by respondents until subsequent rounds of data collection. During file construction, editing was performed for these cases in order to reconcile the round in which a condition began and the round in which the condition was first reported.

Return To Table Of Contents

2.5.2 Medical Condition Variables (AGEDIAG-ICD10CDX)

This PUF contains variables describing medical conditions reported by respondents in several sections of the MEPS questionnaire, and all questionnaire sections collecting information about health provider visits and/or prescription medications (see Variable-Source Crosswalk in Section D for details).

Priority Conditions and Injuries

Certain conditions were a priori designated as “priority conditions” due to their prevalence, expense, or relevance to policy. Some of these are long-term, life-threatening conditions, such as cancer, diabetes, emphysema, high cholesterol, hypertension, ischemic heart disease, and stroke. Others are chronic, manageable conditions, including arthritis and asthma. The only mental health condition on the priority conditions list is attention deficit hyperactivity disorder/attention deficit disorder.

When a condition was first mentioned, respondents were asked whether it was due to an accident or injury (INJURY=1). Only non-priority conditions (i.e., conditions reported in a section other than PE) are eligible to be injuries. The interviewer is prevented from selecting priority conditions as injuries.

Complete List of Conditions Asked in Priority Conditions Enumeration Section:

  • Arthritis

  • Asthma

  • ADHD/ADD

  • Cancer

  • Chronic bronchitis

  • COVID-19 and Long COVID

  • Diabetes

  • Emphysema

  • Heart Disease (including coronary heart disease, angina, myocardial infarction, and other unspecified heart disease)

  • High blood pressure, including multiple diagnoses

  • High cholesterol

  • Joint pain

  • Stroke

Age Priority Condition Began

The age of diagnosis (AGEDIAG) was collected for all priority conditions, except joint pain. For confidentiality reasons, AGEDIAG is set to Inapplicable (-1) for cancer conditions.

To ensure confidentiality, age of diagnosis was top-coded to 85. This corresponds with the age top-coding in person-level PUFs.

Follow-up Questions for Injuries

When a respondent reported that a condition resulted from an accident or injury (INJURY=1), respondents were asked during the round in which the injury was first reported whether the accident/injury occurred at work (ACCDNWRK). This question was not asked about persons aged 15 and younger; the condition had ACCDNWRK coded to inapplicable (-1) for those persons.

Sources for Conditions on the MEPS Conditions File

The records in this PUF correspond with medical condition records collected by CAPI and stored on a person’s MEPS conditions roster. Conditions can be added to the MEPS conditions roster in several ways. A condition can be reported in the Priority Condition Enumeration (PE) section in which persons are asked if they have been diagnosed with specific conditions. The condition can be identified as the reason reported by the household respondent for a particular medical event (hospital stay, outpatient visit, emergency room visit, home health episode, prescribed medication purchase, or office-based medical provider visit). Some condition information is collected in the MPC of MEPS. However, since it is not available for everyone in the sample, it is not used to supplement, replace, or verify household-reported condition data. Conditions reported in the PE section that are not current are not included in this PUF.

Treatment of Data from Rounds Not Occurring in 2022

Prior to the 2008 PUF, priority conditions reported during Rounds 1 and 2 of the second year panel were included in the PUF even if the conditions were not related to an event or reported as a serious condition occurring in the second year of the panel. Beginning in 2008, priority conditions are included in the PUF only if they are also current conditions. From 2008-2017, a current condition was defined as a condition linked to an event or a condition the person was currently experiencing (i.e., a condition selected in the Condition Enumeration (CE) section). However, starting in Panel 21 Round 5 and Panel 22 Round 3, a current condition is defined only as a condition linked to a current year event. Conditions from Panel 24 Rounds 5-7 and Panel 26 Rounds 1-3 that are not included in the 2022 PUF may be available in the 2021 Conditions PUF if the person had a positive person or family weight in 2021.

Note: Priority conditions are generally chronic conditions. Even though a person may not have reported an event in 2022 due to the condition, analysts should consider that the person may still be experiencing the condition. If a Panel 26 person reported a priority condition in Round 1 or 2 and did not have an event for the condition in Round 3, 4, or 5, the condition will not be included on the 2022 Medical Conditions PUF. Similarly: if a Panel 24 person reported a priority condition in Round 1, 2, 3, 4, 5, or 6 and did not have an event for the condition in Round 7, 8, or 9, the condition will not be included on the 2022 Conditions PUF.

Rounds in Which Conditions Were Reported/Selected (CRND1 - CRND9)

A set of constructed variables indicates the round in which the condition was first reported (CONDRN), and the subsequent round(s) in which the condition was selected (CRND1 - CRND9). The condition may be reported or selected when the person reports an event that occurred due to the condition. For example, consider a condition for which CRND1 = 0, CRND2 = 1, and CRND3 = 1. For non-priority conditions (conditions not asked in the PE section), this sequence of indicators on a condition record implies that the condition was not present during Round 1 (CRND1 = 0), was first mentioned during Round 2 (CRND2 = 1, CONDRN = 2), and was selected again during Round 3 (CRND3 = 1). For priority conditions, this sequence of indicators implies that the condition was reported in the PE section in Round 1 (CONDRN = 1, CRND1 = 0) but was not connected with an event until Rounds 2 and 3 (CRND2 = 1, CRND3 = 1). Because priority conditions are asked in the context of “has (person) ever been told by a doctor or other health care professional that they have (condition)?” except joint pain and chronic bronchitis, which ask only about the last 12 months, a priority condition might not be selected in the round in which it was first reported. A condition is current if it is linked to an event that occurred in 2022.

Diagnosis Codes

Medical conditions reported by the HC respondent were recorded by the interviewer using a condition pick-list with ICD-10-CM codes already assigned to conditions in the list. Reported conditions not in the pick-list were recorded as verbatim text and then were coded to ICD-10-CM codes (ICD10CDX) by professional coders.

Coders followed specific guidelines in coding missing values to the ICD-10-CM diagnosis condition variable when a verbatim text string could not be matched to an ICD-10-CM code through the pick-list. ICD10CDX was coded -15 (Cannot be Computed) where the verbatim text fell into one of three categories: (1) the text indicated that the condition was unknown (e.g., DK); (2) the text indicated the condition could not be diagnosed by a doctor (e.g., doctor doesn’t know); or (3) the specified condition was not codable. If the text indicated a procedure and the condition associated with the procedure could be discerned from the text, the condition itself was coded. For example, “cataract surgery” would be coded as the condition “other cataract” (ICD10CDX is set to code “H26”). If the condition could not be discerned (e.g. “outpatient surgery”), ICD10CDX was set to -15.

In order to preserve confidentiality, all of the conditions provided in this PUF have been collapsed to 3-digit diagnosis code categories rather than the fully-specified ICD-10-CM code. For example, the ICD10CDX value of J02 “Acute pharyngitis” includes the fully-specified subclassifications J020 and J029; the value F31 “Bipolar disorder” includes the fully-specified subclassifications F3110 through F319. Table 1 in Appendix 1 provides unweighted and weighted frequencies for all ICD-10-CM condition code values reported in the PUF. Less than 1 percent of the ICD-10-CM codes in this PUF were edited further by collapsing two or more 3-digit codes into one 3-digit code. This includes clinically rare conditions that were recoded to broader codes by clinicians. A condition is determined to be clinically rare if it appears on the National Institutes of Health’s list of rare diseases.

For confidentiality purposes, approximately 10% of ICD-10-CM codes were recoded to -15 (Cannot be Computed) for conditions where the frequency was fewer than 40 for the total unweighted population in the PUF or less than 400,000 for the weighted population. Additional factors used to determine recoding include age and sex.

In a small number of cases, diagnosis and condition codes were recoded to Cannot be Computed (-15) if they denoted a pregnancy for a person younger than 18 or older than 44. Less than one-tenth of 1 percent of records were recoded in this manner on the 2022 Conditions PUF. The person’s age was determined by linking the 2022 Conditions PUF to the 2021 and 2022 Population Characteristics PUF. If the person’s age is under 18 or over 44 in the round in which the pregnancy-related condition was reported, the pregnancy-related condition code was recoded to Cannot be Computed (-15).

Users should note that because of the design of the survey, most deliveries (i.e., births) are coded as pregnancies. For more accurate estimates for deliveries, analysts should use RSNINHOS “Reason Entered Hospital” found on the Hospital Inpatient Stays PUF (HC 239D).

Conditions PUF data can be merged with the 2022 Event PUFs using the 2022 Condition-Event Link PUF (HC 239I). Because the conditions have been collapsed to 3-digit diagnosis code categories rather than the fully-specified ICD-10-CM code, it is possible for there to be duplicate ICD-10-CM condition codes linked to a single medical event when different fully-specified conditions are coded to the same 3-digit code.

Conditions were reported in several sections of the HC questionnaire (see Variable-Source Crosswalk in Section D). Labels for all values of ICD10CDX, as shown in Table 1 of Appendix 1, are provided in the SAS programming statements included in this release (see the H241SU.TXT file).

Clinical Classification Software Refined

Clinical Classification Software Refined (CCSR) codes are used alongside ICD-10-CM diagnosis codes to group medical conditions into clinically meaningful categories. Although ICD-10-CM diagnosis codes can map to multiple CCSR codes, for the purposes of this PUF, one ICD-10-CM diagnosis code may map to up to four CCSR categories (CCSR1X, CCSR2X, CCSR3X, and CCSR4X using the v2023.1 release of the CCSR for ICD-10-CM diagnoses. The CCSR codes on this PUF are listed in alphabetical order and do not indicate a primary and secondary diagnosis. For more information on CCSR, visit the user guide for CCSR.

For confidentiality purposes, approximately 5% of the CCSR categories were collapsed into a broader code for the appropriate body system where the frequency was less than 40 for the total unweighted population in the file or less than 400,000 for the weighted population. For example, BLD001 (Nutritional Anemia), may be recoded to BLD000 (Disease of Blood and Disorders Involving Immune Mechanism), thus revealing only the body system. Less than 1% of CCSR codes were recoded to Cannot be Computed (-15) based on frequencies of ICD10CDX and CCSR pairs.

Table 2 in Appendix 1 provides unweighted and weighted frequencies for CCSR combinations reported in this PUF.

Return To Table Of Contents

2.5.3 Utilization Variables (OBCOND - RXCOND)

The variables OBCOND, OPCOND, HHCOND, IPCOND and ERCOND indicate that at least one 2022 event can be linked to the condition record on the current file, i.e., office-based, outpatient, home health, inpatient hospital stays and emergency room visits. Note that the HHCOND variable includes all home health types, including informal care, and OBCOND and OPCOND include telehealth visits. The variable RXCOND is an indicator of any prescribed medicine purchase associated with the condition.

These event indicators were derived from Expenditure Event PUFs (HC 239G, HC 239F, HC 239H, HC 239D, HC 239E, and HC 239A). Events associated with conditions include all utilization that occurred between January 1, 2022 and December 31, 2022.

Return To Table Of Contents

3.0 Survey Sample Information

3.1 Discussion of Pandemic Effects on Quality of MEPS Data

The challenges associated with MEPS data collection in 2020 after the onset of the COVID-19 pandemic continued through 2021 and possibly into 2022. The major modifications to the standard MEPS study design remained in effect, permitting data to be collected safely but with accompanying concerns related to the quality of the data obtained. The suggestion made in the documentation for the FY 2020 and FY 2021 MEPS Consolidated PUF data still holds. Researchers are counseled to take care in the interpretation of estimates based on data collected from these three calendar years. This includes the comparison of such estimates to those of other years and corresponding trend analyses.

Section 3.1 of the documentation for the 2020 Consolidated PUF provides a general discussion of the impact of the COVID-19 pandemic on several other major in-person federal surveys as well as on MEPS. In addition, it offers a detailed look at how MEPS was modified to permit safe data collection and the development of useful estimates at a time when the way the U.S. health care system functioned underwent many transformations to meet population needs. Three sources of potential bias were identified for MEPS for FY 2020: (1) long recall period for Round 6 of Panel 23, (2) switching from in-person to telephone interviewing which likely had a larger impact on Panel 25, and (3) the impact of CPS bias on the MEPS weights. A number of statistically significant differences were found between panels for FY 2020. Those findings are discussed in MEPS HC 224.

Concerns of potential bias for FY 2021 and between panel differences are discussed in Section 3.1 of the documentation for the 2021 Consolidated PUF. Additional analysis has also uncovered a concerning trend on event reporting in MEPS following the COVID-19 pandemic. While reporting of other event types has rebounded from the dip experienced in 2020, inpatient (IP) and emergency room (ER) utilization reports collected in FY 2021 did not rebound as much as key benchmarks, even though these are the most salient event types. Modifications made to the MEPS sample design discussed in the 2022 Population Characteristics PUF may have partially contributed to the concerning trend.

Concerns for potential bias for FY 2022 include:

  • The impact of the pandemic on NHIS data collection and the resulting Panel 26 MEPS sample (Section 3.1.1 of the 2022 Population Characteristics PUF). NHIS response rates in the pandemic and shifts in the resulting MEPS sample may have increased the likelihood that the MEPS Panel 26 respondents differed in composition compared to previous years.

  • The extension of panels (beginning of Section 3.1 of the 2022 Population Characteristics PUF). While there is a benefit in boosting the MEPS sample size by keeping pre-pandemic panels active for an additional two years to counter reduced response rates, there are two risks with this approach: attrition in these panels beyond what is experienced in two years, which may lead households with more serious health issues to leave MEPS, and a conditioning effect whereby respondents learn over time that reporting events results in a longer interview.

  • Significantly lower response rates (Section 3.2 of the 2022 Population Characteristics PUF) that could differentially exclude households more likely to experience IP stays. The demographic shifts on MEPS between 2019 and 2021 suggest a more educated, higher-income, older MEPS.

Preliminary analyses undertaken to examine the quality of the MEPS FY 2022 data compared health care utilization for the MEPS target population between the panels fielded. These comparisons were undertaken for the full sample and the three age groups of 0-17, 18-64, and 65+.

These comparisons found no major differences in IP or ER visits between the three panels. Slight differences were observed in dental visits and outpatient visits. For dental visits, Panel 26 reported at a higher rate than Panel 24 or Panel 27 in the age range 18-64. For outpatient visits, Panel 24 reported at a lower rate than Panel 26 and Panel 27 in the age range 18-64.

In summary, the weights developed for the MEPS FY 2022 data can be expected to produce useful estimates for initial analyses. Further analyses of MEPS estimates will be conducted as part of the production of the FY 2022 Consolidated PUF to be released later in 2024. This will help identify any additional data quality issues as well as possible improvements that could be implemented.

The various actions taken in the development of the person-level weights for the MEPS FY 2022 data were designed to limit the potential for bias in the data due to changes in data collection and response bias. However, evaluations of MEPS data quality in 2021 and 2022 suggest that users of the MEPS FY 2022 PUFs should continue to exercise caution when interpreting estimates and assessing analyses based on these data, as well as in comparing 2022 estimates to those of prior years.

Return To Table Of Contents

3.2 Sample Weight (PERWT22F)

There is a single full-year person-level weight (PERWT22F) assigned to each record for each Key, in-scope person who responded to MEPS for the full period of time that they were in scope during 2022. A Key person was either a member of a responding NHIS household at the time of the interview or joined a family associated with such a household after being out of scope at the time of the NHIS (the latter circumstance includes newborns as well as those returning from military service, an institution, or residence in a foreign country). A person is in scope whenever they are a member of the civilian noninstitutionalized portion of the U.S. population.

Return To Table Of Contents

3.3 Details on Person Weight Construction

The person-level weight PERWT22F was developed in several stages. First, a person-level weight for Panel 24 was created, including an adjustment for nonresponse over time and raking. The raking involved adjusting to several sets of marginal control totals reflecting Current Population Survey (CPS) population estimates based on six variables. The six variables used in the establishment of the initial person-level control figures were: educational attainment of the reference person (three categories: no degree; high school/GED only or some college; bachelor’s or a higher degree); Census region (Northeast, Midwest, South, West); MSA status (MSA, non-MSA); race/ethnicity (Hispanic; Black, non-Hispanic; Asian, non-Hispanic; and other); sex; and age (0-18, 19-25, 26-34, 35-44, 45-64, and 65 or older). (Note, however, that for confidentiality reasons, the MSA status variables are no longer released for public use.) The person-level weights for Panel 26 and Panel 27 were created similarly. Secondly, a composite weight was formed by multiplying each weight from Panel 24 by the factor .22, each weight from Panel 26 by the factor .29, and each weight from Panel 27 by the factor .49. The choice of factors reflected the relative effective sample sizes of the three panels, helping to limit the variance of estimates obtained from pooling the three samples. Weights for the 2022 Population Characteristics PUF were then developed by raking the composite weight to the same set of CPS-based control totals.

The approach for establishing the 2022 Consolidated PUF weight is as follows. When poverty status information derived from MEPS income variables becomes available, a final raking is undertaken. The full sample weight appearing on the Population Characteristics PUF for a given year is re-raked, replacing educational attainment with poverty status while retaining the other five raking variables previously indicated. Specifically, control totals based on CPS estimates of poverty status (five categories: below poverty, from 100 to 125 percent of poverty, from 125 to 200 percent of poverty, from 200 to 400 percent of poverty, at least 400 percent of poverty) as well as age, race/ethnicity, sex, region, and MSA status are used to calibrate weights.

Return To Table Of Contents

3.3.1 MEPS Panel 24 Weight Development Process

The person-level weight for MEPS Panel 24 was developed using the 2021 full-year weight for an individual as a “base” weight for 2021 survey participants present in 2022. For Key, in-scope members who joined an RU some time in 2022 after being out of scope in 2021, the initially assigned person-level weight was the corresponding 2021 family weight. The weighting process included an adjustment for person-level nonresponse over Rounds 8 and 9 as well as raking to population control figures for December 2022 for Key, responding persons in scope on December 31, 2022. These control totals were derived by scaling back the population distribution obtained from the March 2023 CPS to reflect the December 31, 2022 estimated population total (estimated based on Census projections for January 1, 2023). Variables used for person-level raking included: education of the reference person (three categories: no degree; high school/GED only or some college; bachelor’s or a higher degree); Census region (Northeast, Midwest, South, West); MSA status (MSA, non-MSA); race/ethnicity (Hispanic; Black, non-Hispanic; Asian, non-Hispanic; and other); sex; and age (0-18, 19-25, 26-34, 35-44, 45-64, and 65 or older). (Note, however, that for confidentiality reasons, the MSA status variables are no longer released for public use.) The final weight for Key, responding persons who were not in scope on December 31, 2022 but were in scope earlier in the year was the nonresponse-adjusted person weight without raking.

The 2021 full-year weight used as the base weight for Panel 24 was derived from the 2019 MEPS Round 1 weight and reflected adjustment for nonresponse over the remaining data collection rounds in 2019, 2020, and 2021 as well as raking to the December 2019, December 2020, and December 2021 population control figures.

Return To Table Of Contents

3.3.2 MEPS Panel 26 Weight Development Process

The person-level weight for MEPS Panel 26 was developed by using the 2021 full-year weight as a “base” weight for survey participants present in 2022.

For Key, in-scope members who joined an RU at some time in 2022 after being out of scope in 2021, the initially assigned person-level weight was the corresponding 2021 family weight. The weighting process also included an adjustment for person-level nonresponse over Rounds 4 and 5 as well as raking to the same population control figures for December 2022 used for the Panel 24 weight for Key, responding persons in scope on December 31, 2022. The same six variables used for Panel 24 raking (education level, Census region, MSA status, race/ethnicity, sex, and age) were also used for Panel 26 raking. Similar to Panel 24, the Panel 26 final weight for Key, responding persons not in scope on December 31, 2022 but in scope earlier in the year was the nonresponse-adjusted person weight without raking.

Note that the 2021 full-year weight that was used as the base weight for Panel 26 was derived using the 2021 MEPS Round 1 weight and reflected adjustment for nonresponse over the remaining data collection rounds in 2021 as well as raking to the December 2021 population control figures.

Return To Table Of Contents

3.3.3 MEPS Panel 27 Weight Development Process

The person-level weight for Panel 27 was developed using the 2022 Round 1 person-level weight as a “base” weight. The Round 1 weights incorporated the following components: the original household probability of selection for the NHIS and for the NHIS subsample reserved for the MEPS, an adjustment for NHIS nonresponse, the probability of selection for MEPS from the NHIS, an adjustment for nonresponse at the dwelling unit level for Round 1, and raking to control figures at the person level obtained from the March CPS of the corresponding year. For Key, in-scope members who joined an RU after Round 1, the Round 1 DU weight served as a “base” weight.

The weighting process also included an adjustment for nonresponse over the remaining data collection rounds in 2022 as well as raking to the same population control figures for December 2022 that were used for the Panel 24 and Panel 26 weights for Key, responding persons in scope on December 31, 2022. The same six variables used for Panel 24 and Panel 26 raking (education level of the reference person, Census region, MSA status, race/ethnicity, sex, and age) were also used for Panel 27 raking. Similar to Panel 24 and Panel 26, the Panel 27 final weight for Key, responding persons who were not in scope on December 31, 2022 but were in scope earlier in the year was the nonresponse-adjusted person weight without raking.

Return To Table Of Contents

3.3.4 The Final Weight for 2022

The final raking of those in scope at the end of the year has been described above. In addition, the composite weights of two groups of persons who were out of scope on December 31, 2022 were adjusted for expected undercoverage. Specifically, the weights of those who were out of scope on December 31, 2022, but in scope at some time during the year and were residing in a nursing home at the end of the year were poststratified to an estimate of the number of persons who were residents of Medicare- and Medicaid-certified nursing homes for part of the year (approximately 3-9 months) during 2014. This estimate was developed from data on the Minimum Data Set (MDS) of the Center for Medicare and Medicaid Services (CMS). The weights of persons who died while in scope were poststratified to corresponding estimates derived using data obtained from the Centers for Disease Control and Prevention (CDC), National Center for Health Statistics (NCHS), Provisional Mortality Statistics, 2018 through Last Week on CDC WONDER Online Database, released in 2023, the latest available data at the time. Separate decedent control totals were developed for the “65 and older” and “under 65” civilian noninstitutionalized populations.

Overall, the weighted population estimate for the civilian noninstitutionalized population for December 31, 2022 is 329,059,733 (PERWT22F >0 and INSC1231=1). The sum of person-level weights across all persons assigned a positive person-level weight is 333,053,243.

Return To Table Of Contents

3.4 Coverage

The target population associated with MEPS is the 2022 U.S. civilian noninstitutionalized population. However, the MEPS sampled households are a subsample of the NHIS households interviewed in 2018 (Panel 24), 2020 (Panel 26), and 2021 (Panel 27). New households created after the NHIS interviews for the respective panels and consisting exclusively of persons who entered the target population after 2018 (Panel 24), after 2020 (Panel 26), or after 2021 (Panel 27) are not covered by the 2022 MEPS. Nor are previously out of scope persons who joined an existing household but are not related to the current household residents. Persons not covered by a given MEPS panel thus include some members of the following groups: immigrants, persons leaving the military, U.S. citizens returning from residence in another country, and persons leaving institutions. Those not covered represent a small proportion of the MEPS target population.

Return To Table Of Contents

3.5 Using MEPS Data for Trend Analysis

For analysts using the MEPS data for trend analysis, we note that there are uncertainties associated with 2020, 2021, and possibly 2022 data quality for reasons discussed throughout Section 3. Preliminary evaluations of a set of MEPS estimates of particular importance suggest that they are of reasonable quality. Nevertheless, analysts are advised to exercise caution in interpreting these estimates, particularly in terms of trend analyses, since access to health care was substantially affected by the COVID-19 pandemic, as were related factors such as health insurance and employment status for many persons.

The MEPS began in 1996, and the utility of the survey for analyzing health care trends expands with each additional year of data; however, when examining trends over time using the MEPS, the length of time being analyzed should be considered. In particular, large shifts in survey estimates over short periods of time (e.g. from one year to the next) that are statistically significant should be interpreted with caution unless they are attributable to known factors such as changes in public policy, economic conditions, or the MEPS methodology.

With respect to methodological considerations, changes in data collection methods, such as interviewer training, were introduced in 2013 to obtain more complete information about health care utilization from MEPS respondents; the changes were fully implemented in 2014. This effort likely resulted in improved data quality and a reduction in underreporting starting in the second half of 2013 and continuing throughout 2014 full year files; the changes have also had some impact on analyses involving trends in utilization across years. The changes in the NHIS sample design in 2016 and 2018 could also potentially affect trend analyses. The new NHIS sample design is based on more up-to-date information related to the distribution of housing units across the United States. As a result, it can be expected to better cover the full civilian noninstitutionalized population, the target population for MEPS, as well as many of its subpopulations. Better coverage of the target population helps to reduce the potential for bias in both NHIS and MEPS estimates.

Another change with the potential to affect trend analyses involved major modifications to the MEPS instrument design and data collection process, particularly in the events sections of the instrument. These were introduced in the spring of 2018 and thus affected data beginning with Round 1 of Panel 23, Round 3 of Panel 22, and Round 5 of Panel 21. Since the full year 2017 MEPS files were established from data collected in Rounds 1-3 of Panel 22 and Rounds 3-5 of Panel 21, they reflected two instrument designs. To mitigate the effect of such differences within the same full-year file, the Panel 22 Round 3 data and the Panel 21 Round 5 data were transformed to make them as consistent as possible with data collected under the previous design. The changes in the instrument were designed to make the data collection effort more efficient and easier to administer. In addition, expectations were that data on some items, such as those related to health care events, would be more complete with the potential of identifying more events. Increases in service use reported since the implementation of these changes are consistent with these expectations. Analysts should be aware of the possible impacts of these changes on the data and especially on trend analyses that include the year 2018 because of the design transition.

Process changes, such as data editing and imputation, may also affect trend analyses. For example, users should refer to Section 2.5.11: Utilization, Expenditures, and Sources of Payment Variables in the Consolidated PUF (HC 243) and, for more detail, to the documentation for the prescription drug file (HC 239A) when analyzing prescription drug spending over time. As always, it is recommended that, before conducting trend analyses, analysts should review relevant sections of the documentation for descriptions of these types of changes that might affect the interpretation of changes over time.

To smooth or stabilize trend analyses based on the MEPS data, analysts may also wish to consider using statistical techniques such as comparing pooled time periods (e.g. 1996-1997 versus 2011-2012), working with moving averages, or using modeling techniques with several consecutive years of the data.

Finally, statistical significance tests should be conducted to assess the likelihood that observed trends are not attributable to sampling variation. In addition, researchers should be aware of the impact of multiple comparisons on Type I error. Without making appropriate allowance for multiple comparisons, the use of numerous statistical significance tests of trends will increase the likelihood of concluding that a change has taken place when one has not.

Return To Table Of Contents

4.0 National Health Interview Survey (NHIS)

Data from this PUF can be used alone or in conjunction with other PUFs for different analytic purposes. Each MEPS panel can also be linked back to the previous years’ NHIS public use data files. For information on MEPS/NHIS link files please see the AHRQ website.

Return To Table Of Contents

5.0 Longitudinal Analysis

Panel-specific longitudinal files can be downloaded from the data section of the MEPS website. For all three panels (Panel 24, Panel 26, and Panel 27), the longitudinal file comprises the MEPS survey data obtained in all rounds of the panel and can be used to analyze changes over the entire length of the panel. Variables on the PUF pertaining to survey administration, demographics, employment, health status, disability days, quality of care, patient satisfaction, health insurance, and medical care use and expenditures were obtained from the MEPS Consolidated PUF from the years covered by that panel. For more details or to download the data files, please see Longitudinal Data Files at the AHRQ website.

Return To Table Of Contents

References

Bramlett, M.D., Dahlhamer, J.M., & Bose, J. (2021, September). Weighting Procedures and bias assessment for the 2020 National Health Interview Survey. Hyattsville, MD: National Center for Health Statistics.

Chowdhury, S.R., Machlin, S.R. & Gwet, K.L. Sample designs of the Medical Expenditure Panel Survey Household Component, 1996-2006 and 2007-2016. (2019, January) Methodology Report #33. Rockville, MD: Agency for Healthcare Research and Quality.

Cox, B. and Iachan, R. (1987). A Comparison of Household and Provider Reports of Medical Conditions. Journal of the American Statistical Association 82(400): 1013-18.

Dahlhamer, J.M., Bramlett, M.D., Maitland, A., & Blumberg, S.J. (2021). Preliminary evaluation of nonresponse bias due to the COVID-19 pandemic on National Health Interview Survey estimates, April-June 2020. Hyattsville, MD: National Center for Health Statistics.

Edwards, W. S., Winn, D. M., Kurlantzick, V., et al. Evaluation of National Health Interview Survey Diagnostic Reporting. National Center for Health Statistics, Vital Health 2(120). 1994.

Health Care Financing Administration (1980). International Classification of Diseases, 9th Revision, Clinical Modification (ICD-CM). Vol. 1. (Department of Health and Human Services Pub. No (PHS) 80-1260). Department of Health and Human Services: U.S. Public Health Services.

Johnson, Ayah E., and Sanchez, Maria Elena. (1993), Household and Medical Reports on Medical Conditions: National Medical Expenditure Survey. Journal of Economic and Social Measurement, 19, 199-223.

Lau, D.T., Sosa, P., Dasgupta, N., & He, H. (2021). Impact of the COVID-19 pandemic on Public Health Surveillance and Survey Data Collections in the United States. American Journal of Public Health, 111 (12), pp. 2118-2121.

Rothbaum, J. & Bee, A. (2021, May 3). Coronavirus Infects Surveys, Too: Survey Nonresponse Bias and the Coronavirus Pandemic. Washington, DC: U.S. Census Bureau.

Rothbaum, J. & Bee, A. (2022, September 13). How Has the Pandemic Continued to Affect Survey Response? Using Administrative Data to Evaluate Nonresponse in the 2022 Current Population Survey Annual Social and Economic Supplement. Washington, DC: U.S. Census Bureau.

U.S. Census Bureau. Current Population Survey: 2021 Annual Social and Economic (ASEC) Supplement. (2021). Washington, DC: Author.

Zuvekas, S.H. & Kashihara, D. (2021). The impacts of the COVID-19 pandemic on the Medical Expenditure Panel Survey. American Journal of Public Health, 111 (12), pp. 2157-2166.

Return To Table Of Contents

D. Variable-Source Crosswalk

MEPS HC 241: 2022 MEDICAL CONDITIONS

UNIQUE IDENTIFIER VARIABLES

Variable Label Source1
DUID PANEL # + ENCRYPTED DU IDENTIFIER Assigned In Sampling
PID PERSON NUMBER Assigned In Sampling
DUPERSID PERSON ID (DUID + PID) Assigned In Sampling
CONDN CONDITION NUMBER CAPI Derived
CONDIDX CONDITION ID CAPI Derived
PANEL PANEL NUMBER Constructed
CONDRN CONDITION ROUND NUMBER CAPI Derived

Return To Table Of Contents

MEDICAL CONDITION VARIABLES

Variable Label Source1
AGEDIAG AGE WHEN DIAGNOSED PE section
CRND1 HAS CONDITION INFORMATION IN ROUND 1 Constructed
CRND2 HAS CONDITION INFORMATION IN ROUND 2 Constructed
CRND3 HAS CONDITION INFORMATION IN ROUND 3 Constructed
CRND4 HAS CONDITION INFORMATION IN ROUND 4 Constructed
CRND5 HAS CONDITION INFORMATION IN ROUND 5 Constructed
CRND6 HAS CONDITION INFORMATION IN ROUND 6 Constructed
CRND7 HAS CONDITION INFORMATION IN ROUND 7 Constructed
CRND8 HAS CONDITION INFORMATION IN ROUND 8 Constructed
CRND9 HAS CONDITION INFORMATION IN ROUND 9 Constructed
INJURY WAS CONDITION DUE TO ACCIDENT/INJURY AH80
ACCDNWRK DID ACCIDENT OCCUR AT WORK AH90
ICD10CDX ICD-10-CM CODE FOR CONDITION - EDITED HS40, ER30, OP60, MV70, HH80, PM120, PE Section (Edited)
CCSR1X CLINICAL CLASSIFICATION REFINED CODE 1 EDITED HS40, ER30, OP60, MV70, HH80, PM120, PE section (Edited)
CCSR2X CLINICAL CLASSIFICATION REFINED CODE 2 EDITED HS40, ER30, OP60, MV70, HH80, PM120, PE section (Edited)
CCSR3X CLINICAL CLASSIFICATION REFINED CODE 3 EDITED HS40, ER30, OP60, MV70, HH80, PM120, PE section (Edited)
CCSR4X CLINICAL CLASSIFICATION REFINED CODE 4 EDITED HS40, ER30, OP60, MV70, HH80, PM120, PE section (Edited)

Return To Table Of Contents

UTILIZATION VARIABLES

Variable Label Source1
HHCOND ANY HOME HEALTH EVENTS ASSOC. W/ CONDITION? Constructed
IPCOND ANY INPATIENT EVENTS ASSOC. W/ CONDITION? Constructed
OPCOND ANY OUTPATIENT EVENTS ASSOC. W/ CONDITION? Constructed
OBCOND ANY OFFICE-BASED EVENTS ASSOC W/ CONDITION? Constructed
ERCOND ANY ER EVENTS ASSOC. W/ CONDITION? Constructed
RXCOND ANY PRESCRIBED MEDICINES ASSOC. W/ COND.? Constructed

Return To Table Of Contents

WEIGHTS AND VARIANCE ESTIMATION VARIABLES

Variable Label Source1
PERWT22F EXPENDITURE FILE PERSON WEIGHT, 2022 Constructed
VARSTR VARIANCE ESTIMATION STRATUM, 2022 Constructed
VARPSU VARIANCE ESTIMATION PSU, 2022 Constructed

1See the Household Component section under Survey Questionnaires on the MEPS home page for information on the MEPS HC questionnaire sections shown in the Source column (e.g., PE).

Return To Table Of Contents

Appendix 1

ICD10CDX and CCSR Condition Code Frequencies

Table 1
UNWEIGHTED AND WEIGHTED COUNT OF RECORDS FOR EACH VALUE OF ICD10CDX

ICD10CDX VALUE ICD10CDX LABEL UNWEIGHTED WEIGHTED BY perwt22f
-15 CANNOT BE COMPUTED 7724 105793645.89
A08 VIRAL AND OTHER SPECIFIED INTESTINAL INFECTIONS 111 1763411.82
A49 BACTERIAL INFECTION OF UNSPECIFIED SITE 96 1372210.43
B00 HERPESVIRAL [HERPES SIMPLEX] INFECTIONS 159 1985418.45
B02 ZOSTER [HERPES ZOSTER] 105 1351255.58
B07 VIRAL WARTS 88 1311287.52
B34 VIRAL INFECTION OF UNSPECIFIED SITE 111 1767122.66
B35 DERMATOPHYTOSIS 152 1914471.44
B37 CANDIDIASIS 130 1817606.07
B99 OTHER AND UNSPECIFIED INFECTIOUS DISEASES 42 551101.24
C18 MALIGNANT NEOPLASM OF COLON 61 653379.48
C34 MALIGNANT NEOPLASM OF BRONCHUS AND LUNG 69 700309.77
C43 MALIGNANT MELANOMA OF SKIN 157 2244286.37
C44 OTHER AND UNSPECIFIED MALIGNANT NEOPLASM OF SKIN 481 5860908.20
C50 MALIGNANT NEOPLASM OF BREAST 241 2704320.03
C61 MALIGNANT NEOPLASM OF PROSTATE 193 2197087.29
C73 MALIGNANT NEOPLASM OF THYROID GLAND 56 710952.54
C85 OTH AND UNSPECIFIED TYPES OF NON-HODGKIN LYMPHOMA 45 558597.47
D04 CARCINOMA IN SITU OF SKIN 115 1350239.43
D22 MELANOCYTIC NEVI 100 1339786.50
D48 NEOPLASM OF UNCERTAIN BEHAVIOR OF OTHER AND UNSP SITES 58 788906.88
D49 NEOPLASMS OF UNSPECIFIED BEHAVIOR 136 1603339.66
D50 IRON DEFICIENCY ANEMIA 113 1449114.21
D64 OTHER ANEMIAS 152 1812920.65
E03 OTHER HYPOTHYROIDISM 887 11665200.44
E04 OTHER NONTOXIC GOITER 146 1796736.03
E05 THYROTOXICOSIS [HYPERTHYROIDISM] 163 1859157.61
E06 THYROIDITIS 107 1351517.47
E07 OTHER DISORDERS OF THYROID 376 4612327.16
E11 TYPE 2 DIABETES MELLITUS 2381 27826939.04
E28 OVARIAN DYSFUNCTION 55 1013817.78
E29 TESTICULAR DYSFUNCTION 68 984202.56
E34 OTHER ENDOCRINE DISORDERS 81 1087529.88
E53 DEFICIENCY OF OTHER B GROUP VITAMINS 79 943904.31
E55 VITAMIN D DEFICIENCY 368 4737891.16
E61 DEFICIENCY OF OTHER NUTRIENT ELEMENTS 170 2204621.98
E66 OVERWEIGHT AND OBESITY 178 2361910.34
E78 DISORDERS OF LIPOPROTEIN METABOLISM AND OTHER LIPIDEMIAS 4268 51501123.08
E86 VOLUME DEPLETION 70 830032.89
E87 OTHER DISORDERS OF FLUID, ELECTROLYTE AND ACID-BASE BALANCE 320 3370534.38
F03 UNSPECIFIED DEMENTIA 94 1099205.57
F10 ALCOHOL RELATED DISORDERS 56 898679.77
F20 SCHIZOPHRENIA 45 533485.24
F31 BIPOLAR DISORDER 251 3372331.66
F32 DEPRESSIVE EPISODE 1817 24988757.30
F34 PERSISTENT MOOD [AFFECTIVE] DISORDERS 51 687862.60
F39 UNSPECIFIED MOOD [AFFECTIVE] DISORDER 57 773121.89
F41 OTHER ANXIETY DISORDERS 2158 30338722.04
F42 OBSESSIVE-COMPULSIVE DISORDER 50 782207.50
F43 REACTION TO SEVERE STRESS, AND ADJUSTMENT DISORDERS 462 6382111.83
F80 SPECIFIC DEVELOPMENTAL DISORDERS OF SPEECH AND LANGUAGE 47 833380.05
F84 PERVASIVE DEVELOPMENTAL DISORDERS 106 1831935.15
F90 ATTENTION-DEFICIT HYPERACTIVITY DISORDERS 716 11735380.68
F99 MENTAL DISORDER, NOT OTHERWISE SPECIFIED 271 3900639.47
G20 PARKINSON'S DISEASE 56 766028.81
G25 OTHER EXTRAPYRAMIDAL AND MOVEMENT DISORDERS 139 1495763.13
G35 MULTIPLE SCLEROSIS 53 679112.33
G40 EPILEPSY AND RECURRENT SEIZURES 114 1415951.01
G43 MIGRAINE 496 6910297.07
G45 TRANSIENT CEREBRAL ISCHEMIC ATTACKS AND RELATED SYNDROMES 335 3820830.60
G47 SLEEP DISORDERS 1363 16950504.47
G56 MONONEUROPATHIES OF UPPER LIMB 125 1595935.26
G57 MONONEUROPATHIES OF LOWER LIMB 117 1618917.02
G58 OTHER MONONEUROPATHIES 54 577810.94
G62 OTHER AND UNSPECIFIED POLYNEUROPATHIES 242 2547365.25
G89 PAIN, NOT ELSEWHERE CLASSIFIED 355 4087899.49
H00 HORDEOLUM AND CHALAZION 48 736904.56
H02 OTHER DISORDERS OF EYELID 50 726298.47
H04 DISORDERS OF LACRIMAL SYSTEM 256 3094342.14
H10 CONJUNCTIVITIS 110 1657782.17
H26 OTHER CATARACT 681 7547266.93
H33 RETINAL DETACHMENTS AND BREAKS 73 928592.42
H35 OTHER RETINAL DISORDERS 271 2900387.67
H40 GLAUCOMA 474 5138683.91
H43 DISORDERS OF VITREOUS BODY 63 741332.97
H44 DISORDERS OF GLOBE 92 1181738.85
H52 DISORDERS OF REFRACTION AND ACCOMMODATION 449 7388767.78
H53 VISUAL DISTURBANCES 141 1709633.38
H54 BLINDNESS AND LOW VISION 145 1866183.01
H57 OTHER DISORDERS OF EYE AND ADNEXA 212 2455512.83
H61 OTHER DISORDERS OF EXTERNAL EAR 154 1974082.03
H66 SUPPURATIVE AND UNSPECIFIED OTITIS MEDIA 499 8588109.24
H91 OTHER AND UNSPECIFIED HEARING LOSS 324 3755026.67
H92 OTALGIA AND EFFUSION OF EAR 85 1253498.15
H93 OTHER DISORDERS OF EAR, NOT ELSEWHERE CLASSIFIED 101 1245258.09
I10 ESSENTIAL (PRIMARY) HYPERTENSION 5391 65185339.80
I20 ANGINA PECTORIS 119 1379253.08
I21 ACUTE MYOCARDIAL INFARCTION 416 4869082.73
I25 CHRONIC ISCHEMIC HEART DISEASE 673 7388387.60
I26 PULMONARY EMBOLISM 44 542251.34
I38 ENDOCARDITIS, VALVE UNSPECIFIED 112 1311141.40
I48 ATRIAL FIBRILLATION AND FLUTTER 400 4734196.10
I49 OTHER CARDIAC ARRHYTHMIAS 290 3411268.93
I50 HEART FAILURE 173 1852377.42
I51 COMPLICATIONS AND ILL-DEFINED DESCRIPTIONS OF HEART DISEASE 208 2369344.77
I63 CEREBRAL INFARCTION 57 650954.32
I74 ARTERIAL EMBOLISM AND THROMBOSIS 286 3387794.60
I83 VARICOSE VEINS OF LOWER EXTREMITIES 45 508184.00
I95 HYPOTENSION 58 786108.70
I99 OTHER AND UNSPECIFIED DISORDERS OF CIRCULATORY SYSTEM 54 561754.22
J00 ACUTE NASOPHARYNGITIS [COMMON COLD] 287 4167577.67
J02 ACUTE PHARYNGITIS 506 8412693.35
J06 ACUTE UPPER RESP INFECTIONS OF MULTIPLE AND UNSP SITES 104 1616951.32
J11 INFLUENZA DUE TO UNIDENTIFIED INFLUENZA VIRUS 332 5324113.41
J18 PNEUMONIA, UNSPECIFIED ORGANISM 270 3484876.50
J20 ACUTE BRONCHITIS 70 1100696.15
J30 VASOMOTOR AND ALLERGIC RHINITIS 1015 13460497.74
J32 CHRONIC SINUSITIS 633 9108529.28
J34 OTHER AND UNSPECIFIED DISORDERS OF NOSE AND NASAL SINUSES 194 2308794.77
J39 OTHER DISEASES OF UPPER RESPIRATORY TRACT 96 1326344.93
J40 BRONCHITIS, NOT SPECIFIED AS ACUTE OR CHRONIC 172 2368971.76
J42 UNSPECIFIED CHRONIC BRONCHITIS 132 1385102.32
J43 EMPHYSEMA 116 1312441.83
J44 OTHER CHRONIC OBSTRUCTIVE PULMONARY DISEASE 284 3014198.93
J45 ASTHMA 1548 20111409.55
J98 OTHER RESPIRATORY DISORDERS 204 3251796.90
K04 DISEASES OF PULP AND PERIAPICAL TISSUES 130 1690223.56
K08 OTHER DISORDERS OF TEETH AND SUPPORTING STRUCTURES 253 3909689.43
K13 OTHER DISEASES OF LIP AND ORAL MUCOSA 43 562409.41
K21 GASTRO-ESOPHAGEAL REFLUX DISEASE 1439 17773259.56
K22 OTHER DISEASES OF ESOPHAGUS 73 903395.88
K25 GASTRIC ULCER 73 879971.91
K29 GASTRITIS AND DUODENITIS 101 980642.88
K30 FUNCTIONAL DYSPEPSIA 203 2590958.85
K31 OTHER DISEASES OF STOMACH AND DUODENUM 129 1505460.73
K44 DIAPHRAGMATIC HERNIA 58 695972.79
K46 UNSPECIFIED ABDOMINAL HERNIA 140 1636864.90
K50 CROHN'S DISEASE [REGIONAL ENTERITIS] 47 710465.55
K52 OTHER AND UNSP NONINFECTIVE GASTROENTERITIS AND COLITIS 66 759669.62
K57 DIVERTICULAR DISEASE OF INTESTINE 103 1279503.92
K58 IRRITABLE BOWEL SYNDROME 102 1251427.58
K59 OTHER FUNCTIONAL INTESTINAL DISORDERS 260 3212977.70
K63 OTHER DISEASES OF INTESTINE 227 2727929.94
K64 HEMORRHOIDS AND PERIANAL VENOUS THROMBOSIS 103 1490980.58
K76 OTHER DISEASES OF LIVER 117 1499216.04
K80 CHOLELITHIASIS 51 762964.51
K82 OTHER DISEASES OF GALLBLADDER 73 934799.86
K85 ACUTE PANCREATITIS 44 433318.22
K92 OTHER DISEASES OF DIGESTIVE SYSTEM 121 1559122.27
L02 CUTANEOUS ABSCESS, FURUNCLE AND CARBUNCLE 63 707748.50
L03 CELLULITIS AND ACUTE LYMPHANGITIS 66 755514.72
L08 OTHER LOCAL INFECTIONS OF SKIN AND SUBCUTANEOUS TISSUE 192 2825861.56
L23 ALLERGIC CONTACT DERMATITIS 102 1327973.84
L29 PRURITUS 70 968146.51
L30 OTHER AND UNSPECIFIED DERMATITIS 254 4163989.36
L40 PSORIASIS 119 1737228.40
L60 NAIL DISORDERS 205 2420533.53
L65 OTHER NONSCARRING HAIR LOSS 73 1091734.42
L70 ACNE 221 3705255.21
L71 ROSACEA 103 1289139.36
L72 FOLLICULAR CYSTS OF SKIN AND SUBCUTANEOUS TISSUE 109 1692477.68
L84 CORNS AND CALLOSITIES 79 849454.18
L91 HYPERTROPHIC DISORDERS OF SKIN 66 817990.28
L98 OTH DISORDERS OF SKIN, SUBCU, NOT ELSEWHERE CLASSIFIED 422 5523251.87
M06 OTHER RHEUMATOID ARTHRITIS 428 5044485.15
M10 GOUT 313 4101014.63
M17 OSTEOARTHRITIS OF KNEE 166 1918234.75
M19 OTHER AND UNSPECIFIED OSTEOARTHRITIS 1559 18067504.01
M21 OTHER ACQUIRED DEFORMITIES OF LIMBS 69 763630.53
M25 OTHER JOINT DISORDER, NOT ELSEWHERE CLASSIFIED 1945 24264495.31
M32 SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) 50 558348.57
M35 OTHER SYSTEMIC INVOLVEMENT OF CONNECTIVE TISSUE 62 820571.00
M41 SCOLIOSIS 99 1206440.22
M43 OTHER DEFORMING DORSOPATHIES 54 611629.33
M48 OTHER SPONDYLOPATHIES 126 1505845.94
M50 CERVICAL DISC DISORDERS 62 842680.24
M51 THORACIC, THORACOLUM, AND LUMBOSACRAL INTVRT DISC DISORDERS 288 3371026.89
M53 OTHER AND UNSPECIFIED DORSOPATHIES, NOT ELSEWHERE CLASSIFIED 190 2122303.48
M54 DORSALGIA 1766 22787722.22
M62 OTHER DISORDERS OF MUSCLE 262 3278708.74
M65 SYNOVITIS AND TENOSYNOVITIS 70 971180.31
M71 OTHER BURSOPATHIES 59 641570.68
M72 FIBROBLASTIC DISORDERS 96 1463235.56
M75 SHOULDER LESIONS 177 2176554.27
M77 OTHER ENTHESOPATHIES 138 1747853.66
M79 OTH AND UNSP SOFT TISSUE DISORDERS, NOT ELSEWHERE CLASSIFIED 1102 12816097.92
M81 OSTEOPOROSIS WITHOUT CURRENT PATHOLOGICAL FRACTURE 195 2187897.41
M85 OTHER DISORDERS OF BONE DENSITY AND STRUCTURE 256 2820342.69
M89 OTHER DISORDERS OF BONE 58 557146.32
N15 OTHER RENAL TUBULO-INTERSTITIAL DISEASES 53 640855.49
N18 CHRONIC KIDNEY DISEASE (CKD) 47 553723.57
N19 UNSPECIFIED KIDNEY FAILURE 86 926607.11
N20 CALCULUS OF KIDNEY AND URETER 221 2875300.38
N28 OTH DISORDERS OF KIDNEY AND URETER, NOT ELSEWHERE CLASSIFIED 257 2981008.46
N30 CYSTITIS 94 1095558.89
N32 OTHER DISORDERS OF BLADDER 160 2012213.10
N39 OTHER DISORDERS OF URINARY SYSTEM 742 9325999.80
N40 BENIGN PROSTATIC HYPERPLASIA 335 4192879.56
N42 OTHER AND UNSPECIFIED DISORDERS OF PROSTATE 111 1201825.69
N52 MALE ERECTILE DYSFUNCTION 100 1217755.84
N63 UNSPECIFIED LUMP IN BREAST 67 900235.00
N64 OTHER DISORDERS OF BREAST 51 676558.94
N76 OTHER INFLAMMATION OF VAGINA AND VULVA 61 846586.70
N81 FEMALE GENITAL PROLAPSE 55 703473.02
N83 NONINFLAMMATORY DISORD OF OVARY, FALLOP AND BROAD LIGAMENT 58 977752.29
N89 OTHER NONINFLAMMATORY DISORDERS OF VAGINA 51 628847.15
N92 EXCESSIVE, FREQUENT AND IRREGULAR MENSTRUATION 68 1162753.39
N94 PAIN AND OTH COND ASSOC W FEM GNTL ORG AND MENSTRUAL CYCLE 51 1026815.31
N95 MENOPAUSAL AND OTHER PERIMENOPAUSAL DISORDERS 173 2262108.90
R00 ABNORMALITIES OF HEART BEAT 258 3152704.16
R01 CARDIAC MURMURS AND OTHER CARDIAC SOUNDS 90 999955.33
R03 ABNORMAL BLOOD-PRESSURE READING, WITHOUT DIAGNOSIS 68 767843.63
R05 COUGH 350 5148538.49
R06 ABNORMALITIES OF BREATHING 279 3454249.05
R07 PAIN IN THROAT AND CHEST 169 1961343.05
R09 OTH SYMPTOMS AND SIGNS INVOLVING THE CIRC AND RESP SYS 140 1708608.03
R10 ABDOMINAL AND PELVIC PAIN 318 4280221.35
R11 NAUSEA AND VOMITING 317 4117888.82
R12 HEARTBURN 176 2085299.35
R19 OTH SYMPTOMS AND SIGNS INVOLVING THE DGSTV SYS AND ABDOMEN 132 1431754.54
R20 DISTURBANCES OF SKIN SENSATION 70 823251.29
R21 RASH AND OTHER NONSPECIFIC SKIN ERUPTION 290 4086858.96
R22 LOCALIZED SWELLING, MASS AND LUMP OF SKIN, SUBCU 105 1250557.29
R25 ABNORMAL INVOLUNTARY MOVEMENTS 154 1659306.68
R26 ABNORMALITIES OF GAIT AND MOBILITY 91 974507.02
R32 UNSPECIFIED URINARY INCONTINENCE 203 2319346.11
R33 RETENTION OF URINE 45 688525.45
R35 POLYURIA 49 548038.15
R39 OTH AND UNSP SYMPTOMS AND SIGNS INVOLVING THE GU SYS 45 472046.64
R41 OTH SYMPTOMS AND SIGNS W COGNITIVE FUNCTIONS AND AWARENESS 135 1592375.10
R42 DIZZINESS AND GIDDINESS 298 3620887.01
R47 SPEECH DISTURBANCES, NOT ELSEWHERE CLASSIFIED 45 784919.92
R50 FEVER OF OTHER AND UNKNOWN ORIGIN 136 2200508.14
R51 HEADACHE 166 2346561.84
R52 PAIN, UNSPECIFIED 180 1761405.09
R53 MALAISE AND FATIGUE 149 1738094.65
R54 AGE-RELATED PHYSICAL DEBILITY 92 1031213.00
R55 SYNCOPE AND COLLAPSE 50 489353.63
R56 CONVULSIONS, NOT ELSEWHERE CLASSIFIED 117 1303620.19
R60 EDEMA, NOT ELSEWHERE CLASSIFIED 414 4500458.94
R63 SYMPTOMS AND SIGNS CONCERNING FOOD AND FLUID INTAKE 101 1362224.60
R73 ELEVATED BLOOD GLUCOSE LEVEL 264 3565734.09
R79 OTHER ABNORMAL FINDINGS OF BLOOD CHEMISTRY 53 601083.35
R87 ABNORMAL FINDINGS IN SPECIMENS FROM FEMALE GENITAL ORGANS 41 595009.65
R91 ABNORMAL FINDINGS ON DIAGNOSTIC IMAGING OF LUNG 70 802337.04
S01 OPEN WOUND OF HEAD 40 707435.39
S06 INTRACRANIAL INJURY 82 1304996.54
S09 OTHER AND UNSPECIFIED INJURIES OF HEAD 58 825680.29
S29 OTHER AND UNSPECIFIED INJURIES OF THORAX 45 825749.74
S32 FRACTURE OF LUMBAR SPINE AND PELVIS 53 612829.75
S39 OTH & UNSP INJURIES OF ABD, LOW BACK, PELV & EXTRN GENITALS 183 2562181.55
S42 FRACTURE OF SHOULDER AND UPPER ARM 79 1083370.82
S46 INJURY OF MUSCLE, FASCIA AND TENDON AT SHLDR/UP ARM 50 705448.50
S49 OTHER AND UNSPECIFIED INJURIES OF SHOULDER AND UPPER ARM 108 1483020.73
S61 OPEN WOUND OF WRIST, HAND AND FINGERS 63 770891.55
S62 FRACTURE AT WRIST AND HAND LEVEL 126 1676946.27
S69 OTHER AND UNSPECIFIED INJURIES OF WRIST, HAND AND FINGER(S) 97 1462465.21
S82 FRACTURE OF LOWER LEG, INCLUDING ANKLE 112 1557091.86
S83 DISLOCATION AND SPRAIN OF JOINTS AND LIGAMENTS OF KNEE 97 1471023.03
S89 OTHER AND UNSPECIFIED INJURIES OF LOWER LEG 161 2138776.37
S92 FRACTURE OF FOOT AND TOE, EXCEPT ANKLE 106 1517617.08
S93 DISLOC & SPRAIN OF JOINTS & LIGAMENTS AT ANKL, FT & TOE LEV 105 1608952.20
S99 OTHER AND UNSPECIFIED INJURIES OF ANKLE AND FOOT 109 1493330.50
T14 INJURY OF UNSPECIFIED BODY REGION 369 5025118.09
T63 TOXIC EFFECT OF CONTACT WITH VENOMOUS ANIMALS AND PLANTS 96 1224709.03
T78 ADVERSE EFFECTS, NOT ELSEWHERE CLASSIFIED 406 5011678.09
T88 OTH COMPLICATIONS OF SURGICAL AND MEDICAL CARE, NEC 54 695709.37
U07 EMERGENCY USE OF U07 1880 28662912.31
Z00 ENCNTR FOR GENERAL EXAM W/O COMPLAINT, SUSP OR REPRTD DX 406 6586426.70
Z01 ENCNTR FOR OTH SP EXAM W/O COMPLAINT, SUSPECTED OR REPRTD DX 287 3745856.70
Z04 ENCOUNTER FOR EXAMINATION AND OBSERVATION FOR OTHER REASONS 65 785370.04
Z09 ENCNTR FOR F/U EXAM AFT TRTMT FOR COND OTH THAN MALIG NEOPLM 54 781194.30
Z12 ENCOUNTER FOR SCREENING FOR MALIGNANT NEOPLASMS 384 5083919.21
Z13 ENCOUNTER FOR SCREENING FOR OTHER DISEASES AND DISORDERS 248 2761657.68
Z20 CONTACT W AND (SUSPECTED) EXPOSURE TO COMMUNICABLE DISEASES 822 12299159.08
Z21 ASYMPTOMATIC HUMAN IMMUNODEFICIENCY VIRUS INFECTION STATUS 49 516020.70
Z23 ENCOUNTER FOR IMMUNIZATION 1253 17135676.34
Z29 ENCOUNTER FOR OTHER PROPHYLACTIC MEASURES 117 1387541.97
Z30 ENCOUNTER FOR CONTRACEPTIVE MANAGEMENT 379 6951982.17
Z34 ENCOUNTER FOR SUPERVISION OF NORMAL PREGNANCY 269 4603340.42
Z38 LIVEBORN INFANTS ACCORDING TO PLACE OF BIRTH AND TYPE OF DEL 128 2419281.00
Z48 ENCOUNTER FOR OTHER POSTPROCEDURAL AFTERCARE 58 687780.93
Z51 ENCOUNTER FOR OTHER AFTERCARE AND MEDICAL CARE 52 506026.21
Z63 OTH PROB REL TO PRIM SUPPORT GROUP, INC FAMILY CIRCUMSTANCES 80 1140253.20
Z71 PERSONS ENCNTR HEALTH SERV FOR OTH CNSL AND MED ADVICE, NEC 231 3122806.78
Z76 PERSONS ENCOUNTERING HEALTH SERVICES IN OTHER CIRCUMSTANCES 276 3483822.49
Z79 LONG TERM (CURRENT) DRUG THERAPY 343 4098688.92
Z91 PERSONAL RISK FACTORS, NOT ELSEWHERE CLASSIFIED 85 1485195.28
Z95 PRESENCE OF CARDIAC AND VASCULAR IMPLANTS AND GRAFTS 43 494284.43
Z96 PRESENCE OF OTHER FUNCTIONAL IMPLANTS 237 2835089.49
Z97 PRESENCE OF OTHER DEVICES 78 983375.91
83173 1078987415.99

Table 2
UNWEIGHTED AND WEIGHTED COUNT OF RECORDS FOR EACH VALUE OF CCSR COMBINATION

CCSR1X VALUE CCSR1X LABEL CCSR2X VALUE CCSR2X LABEL CCSR3X VALUE CCSR3X LABEL CCSR4X VALUE CCSR4X LABEL UNWEIGHTED WEIGHTED BY perwt22f
-15 CANNOT BE COMPUTED -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 425 5430056.73
BLD000 DISEASES OF BLOOD AND DISORDERS INVOLVING IMMUNE MECHANIS -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 153 1781901.80
BLD000 DISEASES OF BLOOD AND DISORDERS INVOLVING IMMUNE MECHANIS NEO000 NEOPLASMS -1 INAPPLICABLE -1 INAPPLICABLE 3 26332.02
BLD001 NUTRITIONAL ANEMIA -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 113 1449114.21
BLD003 APLASTIC ANEMIA -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 152 1812920.65
CIR000 DISEASES OF THE CIRCULATORY SYSTEM -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 301 4050436.90
CIR000 DISEASES OF THE CIRCULATORY SYSTEM FAC000 FACTORS INFLUENCING HEALTH STATUS & CONTACT W/ HEALTH SER -1 INAPPLICABLE -1 INAPPLICABLE 14 188777.33
CIR000 DISEASES OF THE CIRCULATORY SYSTEM MUS000 DISEASES OF THE MUSCULOSKELETAL SYSTEM AND CONNECTIVE TIS -1 INAPPLICABLE -1 INAPPLICABLE 2 27802.95
CIR000 DISEASES OF THE CIRCULATORY SYSTEM PRG000 PREGNANCY, CHILDBIRTH AND THE PUERPERIUM -1 INAPPLICABLE -1 INAPPLICABLE 1 .00
CIR003 NONRHEUMATIC AND UNSPECIFIED VALVE DISORDERS -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 44 664939.92
CIR004 ENDOCARDITIS AND ENDOCARDIAL DISEASE -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 112 1311141.40
CIR007 ESSENTIAL HYPERTENSION -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 5391 65185339.80
CIR009 ACUTE MYOCARDIAL INFARCTION -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 416 4869082.73
CIR011 CORONARY ATHEROSCLEROSIS AND OTHER HEART DISEASE -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 792 8767640.68
CIR011 CORONARY ATHEROSCLEROSIS AND OTHER HEART DISEASE FAC009 IMPLANT, DEVICE OR GRAFT RELATED ENCOUNTER -1 INAPPLICABLE -1 INAPPLICABLE 43 494284.43
CIR012 NONSPECIFIC CHEST PAIN -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 169 1961343.05
CIR013 ACUTE PULMONARY EMBOLISM -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 44 542251.34
CIR015 OTHER AND ILL-DEFINED HEART DISEASE -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 208 2369344.77
CIR016 CONDUCTION DISORDERS FAC009 IMPLANT, DEVICE OR GRAFT RELATED ENCOUNTER -1 INAPPLICABLE -1 INAPPLICABLE 61 777852.61
CIR017 CARDIAC DYSRHYTHMIAS -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 690 8145465.03
CIR019 HEART FAILURE -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 173 1852377.42
CIR020 CEREBRAL INFARCTION -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 57 650954.32
CIR026 PERIPHERAL AND VISCERAL VASCULAR DISEASE -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 52 615174.52
CIR030 AORTIC AND PERIPHERAL ARTERIAL EMBOLISM OR THROMBOSIS -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 286 3387794.60
CIR031 HYPOTENSION -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 58 786108.70
CIR032 OTHER SPECIFIED AND UNSPECIFIED CIRCULATORY DISEASE -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 54 561754.22
CIR035 VARICOSE VEINS OF LOWER EXTREMITY -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 45 508184.00
CIR039 OTHER SPECIFIED DISEASES OF VEINS AND LYMPHATICS -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 74 836059.18
DEN000 DENTAL DISEASES DIG000 DISEASES OF THE DIGESTIVE SYSTEM -1 INAPPLICABLE -1 INAPPLICABLE 25 321775.50
DEN000 DENTAL DISEASES DIG000 DISEASES OF THE DIGESTIVE SYSTEM INF000 CERTAIN INFECTIOUS AND PARASITIC DISEASES -1 INAPPLICABLE 49 626776.12
DEN000 DENTAL DISEASES DIG000 DISEASES OF THE DIGESTIVE SYSTEM MUS000 DISEASES OF THE MUSCULOSKELETAL SYSTEM AND CONNECTIVE TIS -1 INAPPLICABLE 1 9078.57
DEN000 DENTAL DISEASES FAC000 FACTORS INFLUENCING HEALTH STATUS & CONTACT W/ HEALTH SER -1 INAPPLICABLE -1 INAPPLICABLE 22 333903.46
DEN000 DENTAL DISEASES INJ000 INJURY, POISONING & CERTAIN OTH CONSEQUENCES OF EXTNL CAU -1 INAPPLICABLE -1 INAPPLICABLE 38 456715.41
DEN000 DENTAL DISEASES MUS000 DISEASES OF THE MUSCULOSKELETAL SYSTEM AND CONNECTIVE TIS -1 INAPPLICABLE -1 INAPPLICABLE 36 486716.27
DEN001 ANY DENTAL CONDITION INCLUDING TRAUMATIC INJURY DEN002 NONTRAUMATIC DENTAL CONDITIONS DEN003 CARIES, PERIODONTITIS, AND OTHER PREVENTABLE DENTAL CONDS DIG002 DISORDERS OF TEETH AND GINGIVA 346 5342765.19
DEN001 ANY DENTAL CONDITION INCLUDING TRAUMATIC INJURY DEN002 NONTRAUMATIC DENTAL CONDITIONS DEN003 CARIES, PERIODONTITIS, AND OTHER PREVENTABLE DENTAL CONDS FAC014 MEDICAL EXAMINATION/EVALUATION 80 886955.95
DEN001 ANY DENTAL CONDITION INCLUDING TRAUMATIC INJURY DEN002 NONTRAUMATIC DENTAL CONDITIONS DIG002 DISORDERS OF TEETH AND GINGIVA -1 INAPPLICABLE 203 3062895.60
DEN001 ANY DENTAL CONDITION INCLUDING TRAUMATIC INJURY DEN002 NONTRAUMATIC DENTAL CONDITIONS DIG003 DISEASES OF MOUTH; EXCLUDING DENTAL -1 INAPPLICABLE 43 562409.41
DEN001 ANY DENTAL CONDITION INCLUDING TRAUMATIC INJURY INJ048 OPEN WOUNDS OF HEAD AND NECK, SUBSEQUENT ENCOUNTER -1 INAPPLICABLE -1 INAPPLICABLE 40 707435.39
DIG000 DISEASES OF THE DIGESTIVE SYSTEM -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 329 4755849.72
DIG000 DISEASES OF THE DIGESTIVE SYSTEM INF000 CERTAIN INFECTIOUS AND PARASITIC DISEASES -1 INAPPLICABLE -1 INAPPLICABLE 64 793733.09
DIG000 DISEASES OF THE DIGESTIVE SYSTEM INJ000 INJURY, POISONING & CERTAIN OTH CONSEQUENCES OF EXTNL CAU -1 INAPPLICABLE -1 INAPPLICABLE 1 25876.28
DIG000 DISEASES OF THE DIGESTIVE SYSTEM MUS000 DISEASES OF THE MUSCULOSKELETAL SYSTEM AND CONNECTIVE TIS -1 INAPPLICABLE -1 INAPPLICABLE 1 23805.64
DIG001 INTESTINAL INFECTION INF008 VIRAL INFECTION -1 INAPPLICABLE -1 INAPPLICABLE 111 1763411.82
DIG004 ESOPHAGEAL DISORDERS -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 1512 18676655.44
DIG005 GASTRODUODENAL ULCER -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 73 879971.91
DIG007 GASTRITIS AND DUODENITIS -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 101 980642.88
DIG008 OTH SPECIFIED & UNSPECIFIED DISORDERS OF STOMACH & DUODEN -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 332 4096419.58
DIG010 ABDOMINAL HERNIA -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 198 2332837.69
DIG011 REGIONAL ENTERITIS AND ULCERATIVE COLITIS -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 47 710465.55
DIG013 DIVERTICULOSIS AND DIVERTICULITIS -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 103 1279503.92
DIG014 HEMORRHOIDS -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 103 1490980.58
DIG017 BILIARY TRACT DISEASE -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 124 1697764.37
DIG019 OTHER SPECIFIED AND UNSPECIFIED LIVER DISEASE -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 117 1499216.04
DIG020 PANCREATIC DISORDERS (EXCLUDING DIABETES) -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 44 433318.22
DIG021 GASTROINTESTINAL HEMORRHAGE -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 62 666103.48
DIG022 NONINFECTIOUS GASTROENTERITIS -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 66 759669.62
DIG025 OTHER SPECIFIED AND UNSPECIFIED GASTROINTESTINAL DISORDER -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 562 7015893.81
EAR000 DISEASES OF THE EAR AND MASTOID PROCESS -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 83 1274261.70
EAR001 OTITIS MEDIA -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 499 8588109.24
EAR004 HEARING LOSS -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 324 3755026.67
EAR006 OTHER SPECIFIED AND UNSPECIFIED DISORDERS OF THE EAR -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 340 4472838.27
END000 ENDOCRINE, NUTRITIONAL AND METABOLIC DISEASES -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 102 1369021.28
END000 ENDOCRINE, NUTRITIONAL AND METABOLIC DISEASES EYE000 DISEASES OF THE EYE AND ADNEXA -1 INAPPLICABLE -1 INAPPLICABLE 23 273482.29
END000 ENDOCRINE, NUTRITIONAL AND METABOLIC DISEASES GEN000 DISEASES OF THE GENITOURINARY SYSTEM -1 INAPPLICABLE -1 INAPPLICABLE 20 289064.24
END000 ENDOCRINE, NUTRITIONAL AND METABOLIC DISEASES SKN000 DISEASES OF THE SKIN AND SUBCUTANEOUS TISSUE -1 INAPPLICABLE -1 INAPPLICABLE 8 97130.69
END001 THYROID DISORDERS -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 1679 21284938.71
END002 DIABETES MELLITUS WITHOUT COMPLICATION END005 DIABETES MELLITUS, TYPE 2 -1 INAPPLICABLE -1 INAPPLICABLE 2334 27311599.46
END003 DIABETES MELLITUS WITH COMPLICATION END005 DIABETES MELLITUS, TYPE 2 NVS020 OTH NERV SYS DISORDERS (NEITHER HEREDITARY OR DEGENERATIV -1 INAPPLICABLE 47 515339.58
END007 NUTRITIONAL DEFICIENCIES -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 688 8831511.55
END009 OBESITY -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 118 1614327.01
END010 DISORDERS OF LIPID METABOLISM -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 4268 51501123.08
END011 FLUID AND ELECTROLYTE DISORDERS -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 390 4200567.27
END015 OTHER SPECIFIED AND UNSPECIFIED ENDOCRINE DISORDERS -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 260 3869777.45
END016 OTH SPECIFIED & UNSPEC NUTRITIONAL AND METABOLIC DISORDER -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 166 2198345.54
EXT000 EXTERNAL CAUSES OF MORBIDITY INJ000 INJURY, POISONING & CERTAIN OTH CONSEQUENCES OF EXTNL CAU -1 INAPPLICABLE -1 INAPPLICABLE 3 29741.24
EXT000 EXTERNAL CAUSES OF MORBIDITY INJ000 INJURY, POISONING & CERTAIN OTH CONSEQUENCES OF EXTNL CAU MBD000 MENTAL, BEHAVIORAL AND NEURODEVELOPMENTAL DISORDERS -1 INAPPLICABLE 12 168315.72
EYE000 DISEASES OF THE EYE AND ADNEXA -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 143 1997989.04
EYE000 DISEASES OF THE EYE AND ADNEXA INF000 CERTAIN INFECTIOUS AND PARASITIC DISEASES -1 INAPPLICABLE -1 INAPPLICABLE 2 23314.50
EYE001 CORNEA AND EXTERNAL DISEASE -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 200 2905054.94
EYE002 CATARACT AND OTHER LENS DISORDERS -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 681 7547266.93
EYE003 GLAUCOMA -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 474 5138683.91
EYE004 UVEITIS AND OCULAR INFLAMMATION -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 92 1181738.85
EYE005 RETINAL AND VITREOUS CONDITIONS -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 407 4570313.06
EYE008 OCULOFACIAL PLASTICS AND ORBITAL CONDITIONS -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 306 3820640.61
EYE009 REFRACTIVE ERROR -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 449 7388767.78
EYE010 BLINDNESS AND VISION DEFECTS -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 286 3575816.38
EYE012 OTHER SPECIFIED EYE DISORDERS -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 212 2455512.83
FAC000 FACTORS INFLUENCING HEALTH STATUS & CONTACT W/ HEALTH SER -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 300 4671193.30
FAC003 ENCTR FOR OBS, EXAM COND R/O, EXCL INFECT DIS, NPL, MENT -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 313 3547027.72
FAC005 ENCOUNTER FOR PROPHYLACTIC MEASURES (EXCLUDES IMMUNIZATIO -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 117 1387541.97
FAC008 NEOPLASM-RELATED ENCOUNTERS -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 384 5083919.21
FAC009 IMPLANT, DEVICE OR GRAFT RELATED ENCOUNTER -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 407 4950809.95
FAC010 OTHER AFTERCARE ENCOUNTER -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 164 1975001.44
FAC012 OTHER SPECIFIED ENCOUNTERS AND COUNSELING -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 507 6606629.28
FAC013 CONTRACEPTIVE AND PROCREATIVE MANAGEMENT -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 379 6951982.17
FAC014 MEDICAL EXAMINATION/EVALUATION -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 613 9445327.44
FAC016 EXPOSURE, ENCTR, SCREENING OR CONTACT W/ INFECTIOUS DISEA -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 2075 29434835.42
FAC019 SOCIOECONOMIC/PSYCHOSOCIAL FACTORS -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 80 1140253.20
FAC020 LIFESTYLE/LIFE MANAGEMENT FACTORS -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 40 490302.35
FAC022 ACQUIRED ABSENCE OF LIMB OR ORGAN -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 67 820731.14
FAC025 OTHER SPECIFIED STATUS -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 428 5583884.20
GEN000 DISEASES OF THE GENITOURINARY SYSTEM -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 247 3402239.16
GEN000 DISEASES OF THE GENITOURINARY SYSTEM INF000 CERTAIN INFECTIOUS AND PARASITIC DISEASES -1 INAPPLICABLE -1 INAPPLICABLE 3 66071.04
GEN001 NEPHRITIS; NEPHROSIS; RENAL SCLEROSIS -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 53 640855.49
GEN002 ACUTE AND UNSPECIFIED RENAL FAILURE -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 86 926607.11
GEN003 CHRONIC KIDNEY DISEASE -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 47 553723.57
GEN004 URINARY TRACT INFECTIONS -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 756 9614860.68
GEN005 CALCULUS OF URINARY TRACT -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 221 2875300.38
GEN006 OTH SPECIFIED AND UNSPECIFIED DISEASES OF KIDNEY AND URET -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 257 2981008.46
GEN007 OTH SPECIFIED & UNSPECIFIED DISEASES OF BLADDER AND URETH -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 160 2012213.10
GEN008 URINARY INCONTINENCE -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 203 2319346.11
GEN012 HYPERPLASIA OF PROSTATE -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 335 4192879.56
GEN014 ERECTILE DYSFUNCTION -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 100 1217755.84
GEN016 OTHER SPECIFIED MALE GENITAL DISORDERS -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 111 1201825.69
GEN017 NONMALIGNANT BREAST CONDITIONS -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 171 2308366.97
GEN018 INFLAMMATORY DISEASES OF FEMALE PELVIC ORGANS -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 61 846586.70
GEN018 INFLAMMATORY DISEASES OF FEMALE PELVIC ORGANS GEN025 OTHER SPECIFIED FEMALE GENITAL DISORDERS INF004 FUNGAL INFECTIONS -1 INAPPLICABLE 77 1241775.55
GEN020 PROLAPSE OF FEMALE GENITAL ORGANS -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 55 703473.02
GEN021 MENSTRUAL DISORDERS -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 119 2189568.71
GEN022 BENIGN OVARIAN CYST -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 58 977752.29
GEN023 MENOPAUSAL DISORDERS -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 173 2262108.90
GEN025 OTHER SPECIFIED FEMALE GENITAL DISORDERS -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 172 2271784.82
INF000 CERTAIN INFECTIOUS AND PARASITIC DISEASES -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 236 2906539.08
INF000 CERTAIN INFECTIOUS AND PARASITIC DISEASES MUS000 DISEASES OF THE MUSCULOSKELETAL SYSTEM AND CONNECTIVE TIS -1 INAPPLICABLE -1 INAPPLICABLE 7 91354.92
INF000 CERTAIN INFECTIOUS AND PARASITIC DISEASES NVS000 DISEASES OF THE NERVOUS SYSTEM -1 INAPPLICABLE -1 INAPPLICABLE 2 19070.37
INF000 CERTAIN INFECTIOUS AND PARASITIC DISEASES PNL000 CERTAIN CONDITIONS ORIGINATING IN THE PERINATAL PERIOD -1 INAPPLICABLE -1 INAPPLICABLE 6 142517.23
INF000 CERTAIN INFECTIOUS AND PARASITIC DISEASES RSP000 DISEASES OF THE RESPIRATORY SYSTEM -1 INAPPLICABLE -1 INAPPLICABLE 7 70475.05
INF000 CERTAIN INFECTIOUS AND PARASITIC DISEASES SKN000 DISEASES OF THE SKIN AND SUBCUTANEOUS TISSUE -1 INAPPLICABLE -1 INAPPLICABLE 5 59034.48
INF003 BACTERIAL INFECTIONS -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 96 1372210.43
INF003 BACTERIAL INFECTIONS RSP006 OTHER SPECIFIED UPPER RESPIRATORY INFECTIONS -1 INAPPLICABLE -1 INAPPLICABLE 318 5516593.35
INF004 FUNGAL INFECTIONS -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 289 3621296.62
INF006 HIV INFECTION -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 49 516020.70
INF008 VIRAL INFECTION -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 352 4941696.80
INF008 VIRAL INFECTION SKN007 OTHER SPECIFIED AND UNSPECIFIED SKIN DISORDERS -1 INAPPLICABLE -1 INAPPLICABLE 111 1473387.40
INF009 PARASITIC, OTHER SPECIFIED AND UNSPECIFIED INFECTIONS -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 42 551101.24
INF012 CORONAVIRUS DISEASE - 2019 (COVID-19) -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 1880 28662912.31
INJ000 INJURY, POISONING & CERTAIN OTH CONSEQUENCES OF EXTNL CAU -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 341 4372579.71
INJ000 INJURY, POISONING & CERTAIN OTH CONSEQUENCES OF EXTNL CAU MBD000 MENTAL, BEHAVIORAL AND NEURODEVELOPMENTAL DISORDERS -1 INAPPLICABLE -1 INAPPLICABLE 4 43263.65
INJ000 INJURY, POISONING & CERTAIN OTH CONSEQUENCES OF EXTNL CAU MUS000 DISEASES OF THE MUSCULOSKELETAL SYSTEM AND CONNECTIVE TIS -1 INAPPLICABLE -1 INAPPLICABLE 1 13863.88
INJ000 INJURY, POISONING & CERTAIN OTH CONSEQUENCES OF EXTNL CAU NVS000 DISEASES OF THE NERVOUS SYSTEM -1 INAPPLICABLE -1 INAPPLICABLE 4 41709.12
INJ000 INJURY, POISONING & CERTAIN OTH CONSEQUENCES OF EXTNL CAU SKN000 DISEASES OF THE SKIN AND SUBCUTANEOUS TISSUE -1 INAPPLICABLE -1 INAPPLICABLE 42 628711.21
INJ027 OTHER UNSPECIFIED INJURY -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 77 1113339.44
INJ031 ALLERGIC REACTIONS RSP007 OTHER SPECIFIED AND UNSPECIFIED UPPER RESPIRATORY DISEASE -1 INAPPLICABLE -1 INAPPLICABLE 1015 13460497.74
INJ031 ALLERGIC REACTIONS SKN005 CONTACT DERMATITIS -1 INAPPLICABLE -1 INAPPLICABLE 102 1327973.84
INJ031 ALLERGIC REACTIONS SKN007 OTHER SPECIFIED AND UNSPECIFIED SKIN DISORDERS -1 INAPPLICABLE -1 INAPPLICABLE 254 4163989.36
INJ039 FRACTURE OF THE SPINE AND BACK, SUBSEQUENT ENCOUNTER -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 53 612829.75
INJ041 FRACTURE OF THE UPPER LIMB, SUBSEQUENT ENCOUNTER -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 205 2760317.09
INJ042 FRACTURE OF LOWER LIMB (EXCEPT HIP), SUBSEQUENT ENCOUNTER -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 218 3074708.94
INJ045 TRAUMATIC BRAIN INJURY (TBI); CONCUSSION, SUBSEQUENT ENCT -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 82 1304996.54
INJ049 OPEN WOUNDS TO LIMBS, SUBSEQUENT ENCOUNTER -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 109 1357069.38
INJ054 SUPERFICIAL INJURY; CONTUSION, SUBSEQUENT ENCOUNTER -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 80 1110329.63
INJ060 TOXIC EFFECTS, SUBSEQUENT ENCOUNTER -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 96 1224709.03
INJ061 SPRAINS AND STRAINS, SUBSEQUENT ENCOUNTER -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 568 8704770.50
INJ064 OTHER UNSPECIFIED INJURIES, SUBSEQUENT ENCOUNTER -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 1046 14432133.41
INJ067 ALLERGIC REACTIONS, SUBSEQUENT ENCOUNTER -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 406 5011678.09
INJ072 COMPLC OF OTHER SURGICAL/MEDICAL CARE, INJURY, SUBSEQ ENC -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 54 695709.37
MAL000 CONGENITAL MALFORMATIONS, DEFORMATIONS & CHROMOSOMAL ABNO -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 100 1746049.67
MBD000 MENTAL, BEHAVIORAL AND NEURODEVELOPMENTAL DISORDERS -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 349 5226898.65
MBD000 MENTAL, BEHAVIORAL AND NEURODEVELOPMENTAL DISORDERS PRG000 PREGNANCY, CHILDBIRTH AND THE PUERPERIUM -1 INAPPLICABLE -1 INAPPLICABLE 22 374892.59
MBD001 SCHIZOPHRENIA SPECTRUM AND OTHER PSYCHOTIC DISORDERS -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 45 533485.24
MBD002 DEPRESSIVE DISORDERS -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 1817 24988757.30
MBD003 BIPOLAR AND RELATED DISORDERS -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 251 3372331.66
MBD004 OTHER SPECIFIED AND UNSPECIFIED MOOD DISORDERS -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 108 1460984.49
MBD005 ANXIETY AND FEAR-RELATED DISORDERS -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 2158 30338722.04
MBD006 OBSESSIVE-COMPULSIVE AND RELATED DISORDERS -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 50 782207.50
MBD007 TRAUMA- AND STRESSOR-RELATED DISORDERS -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 462 6382111.83
MBD013 MISCELLANEOUS MENTAL AND BEHAVIORAL DISORDERS/CONDITIONS -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 271 3900639.47
MBD014 NEURODEVELOPMENTAL DISORDERS -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 869 14400695.88
MBD017 ALCOHOL-RELATED DISORDERS -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 56 898679.77
MUS000 DISEASES OF THE MUSCULOSKELETAL SYSTEM AND CONNECTIVE TIS -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 263 3911832.97
MUS000 DISEASES OF THE MUSCULOSKELETAL SYSTEM AND CONNECTIVE TIS SKN000 DISEASES OF THE SKIN AND SUBCUTANEOUS TISSUE -1 INAPPLICABLE -1 INAPPLICABLE 34 578425.91
MUS003 RHEUMATOID ARTHRITIS AND RELATED DISEASE -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 428 5044485.15
MUS006 OSTEOARTHRITIS -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 1725 19985738.75
MUS007 OTHER SPECIFIED JOINT DISORDERS -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 326 3767010.25
MUS009 TENDON AND SYNOVIAL DISORDERS -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 351 4375144.14
MUS010 MUSCULOSKELETAL PAIN, NOT LOW BACK PAIN -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 3061 39079795.59
MUS011 SPONDYLOPATHIES/SPONDYLOARTHROPATHY (INCLUDING INFECTIVE) -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 866 10507051.55
MUS011 SPONDYLOPATHIES/SPONDYLOARTHROPATHY (INCLUDING INFECTIVE) MUS038 LOW BACK PAIN -1 INAPPLICABLE -1 INAPPLICABLE 492 5555753.08
MUS013 OSTEOPOROSIS -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 195 2187897.41
MUS021 ACQUIRED FOOT DEFORMITIES -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 69 763630.53
MUS022 SCOLIOSIS AND OTHER POSTURAL DORSOPATHIC DEFORMITIES -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 99 1206440.22
MUS024 SYSTEMIC LUPUS ERYTHEMATOSUS AND CONNECTIVE TISSUE DISORD -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 112 1378919.58
MUS025 OTHER SPECIFIED CONNECTIVE TISSUE DISEASE -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 822 9933727.23
MUS026 MUSCLE DISORDERS -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 165 1913265.63
MUS028 OTHER SPECIFIED BONE DISEASE AND MUSCULOSKELETAL DEFORMIT -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 314 3377489.01
MUS033 GOUT -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 313 4101014.63
MUS038 LOW BACK PAIN -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 417 5442282.50
NEO000 NEOPLASMS -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 390 4514562.05
NEO015 GASTROINTESTINAL CANCERS - COLORECTAL -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 61 653379.48
NEO022 RESPIRATORY CANCERS -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 69 700309.77
NEO025 SKIN CANCERS - MELANOMA -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 157 2244286.37
NEO026 SKIN CANCERS - BASAL CELL CARCINOMA -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 85 1136148.47
NEO027 SKIN CANCERS - SQUAMOUS CELL CARCINOMA -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 65 705919.57
NEO028 SKIN CANCERS - ALL OTHER TYPES -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 446 5369079.58
NEO030 BREAST CANCER - ALL OTHER TYPES -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 241 2704320.03
NEO039 MALE REPRODUCTIVE SYSTEM CANCERS - PROSTATE -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 193 2197087.29
NEO050 ENDOCRINE SYSTEM CANCERS - THYROID -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 56 710952.54
NEO058 NON-HODGKIN LYMPHOMA -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 45 558597.47
NEO072 NEOPLASMS OF UNSPECIFIED NATURE OR UNCERTAIN BEHAVIOR -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 194 2392246.54
NEO073 BENIGN NEOPLASMS -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 385 4938957.88
NVS000 DISEASES OF THE NERVOUS SYSTEM -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 181 2167684.56
NVS000 DISEASES OF THE NERVOUS SYSTEM SYM000 SYMPTOMS, SIGNS AND ABNORMAL CLINICAL & LAB FINDINGS, NEC -1 INAPPLICABLE -1 INAPPLICABLE 3 59236.85
NVS004 PARKINSON`S DISEASE -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 56 766028.81
NVS005 MULTIPLE SCLEROSIS -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 53 679112.33
NVS006 OTHER NERV SYS DISORDERS (OFTEN HEREDITARY OR DEGENERATIV -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 48 650023.96
NVS006 OTHER NERV SYS DISORDERS (OFTEN HEREDITARY OR DEGENERATIV NVS016 SLEEP WAKE DISORDERS -1 INAPPLICABLE -1 INAPPLICABLE 139 1495763.13
NVS009 EPILEPSY; CONVULSIONS -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 231 2719571.20
NVS010 HEADACHE; INCLUDING MIGRAINE -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 496 6910297.07
NVS010 HEADACHE; INCLUDING MIGRAINE SYM010 NERVOUS SYSTEM SIGNS AND SYMPTOMS -1 INAPPLICABLE -1 INAPPLICABLE 166 2346561.84
NVS011 NEUROCOGNITIVE DISORDERS -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 136 1562700.43
NVS012 TRANSIENT CEREBRAL ISCHEMIA -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 335 3820830.60
NVS015 POLYNEUROPATHIES -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 242 2547365.25
NVS016 SLEEP WAKE DISORDERS -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 1363 16950504.47
NVS017 NERVE AND NERVE ROOT DISORDERS -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 341 4362418.75
NVS019 NERVOUS SYSTEM PAIN AND PAIN SYNDROMES -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 355 4087899.49
PNL000 CERTAIN CONDITIONS ORIGINATING IN THE PERINATAL PERIOD -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 8 196137.86
PNL001 LIVEBORN -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 128 2419281.00
PRG000 PREGNANCY, CHILDBIRTH AND THE PUERPERIUM -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 151 2389038.26
PRG000 PREGNANCY, CHILDBIRTH AND THE PUERPERIUM SYM000 SYMPTOMS, SIGNS AND ABNORMAL CLINICAL & LAB FINDINGS, NEC -1 INAPPLICABLE -1 INAPPLICABLE 2 40713.56
PRG029 UNCOMPLICATED PREGNANCY, DELIVERY OR PUERPERIUM -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 269 4603340.42
RSP000 DISEASES OF THE RESPIRATORY SYSTEM -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 154 2223115.86
RSP001 SINUSITIS -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 633 9108529.28
RSP002 PNEUMONIA (EXCEPT THAT CAUSED BY TUBERCULOSIS) -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 270 3484876.50
RSP003 INFLUENZA -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 332 5324113.41
RSP004 ACUTE AND CHRONIC TONSILLITIS -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 69 1526052.23
RSP005 ACUTE BRONCHITIS -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 242 3469667.91
RSP006 OTHER SPECIFIED UPPER RESPIRATORY INFECTIONS -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 579 8680628.99
RSP007 OTHER SPECIFIED AND UNSPECIFIED UPPER RESPIRATORY DISEASE -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 290 3635139.71
RSP008 CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND BRONCHIECTASIS -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 532 5711743.08
RSP009 ASTHMA -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 1548 20111409.55
RSP016 OTHER SPECIFIED AND UNSPECIFIED LOWER RESPIRATORY DISEASE -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 204 3251796.90
SKN000 DISEASES OF THE SKIN AND SUBCUTANEOUS TISSUE -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 91 1350429.42
SKN001 SKIN AND SUBCUTANEOUS TISSUE INFECTIONS -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 321 4289124.78
SKN002 OTHER SPECIFIED INFLAMMATORY CONDITION OF SKIN -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 589 8676477.44
SKN007 OTHER SPECIFIED AND UNSPECIFIED SKIN DISORDERS -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 1138 14751027.99
SYM000 SYMPTOMS, SIGNS AND ABNORMAL CLINICAL & LAB FINDINGS, NEC -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 190 2406374.23
SYM001 SYNCOPE -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 50 489353.63
SYM002 FEVER -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 136 2200508.14
SYM004 NAUSEA AND VOMITING -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 317 4117888.82
SYM006 ABDOMINAL PAIN & OTHER DIGESTIVE/ABDOMEN SIGNS AND SYMPTO -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 670 8445009.76
SYM007 MALAISE AND FATIGUE -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 149 1738094.65
SYM010 NERVOUS SYSTEM SIGNS AND SYMPTOMS -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 343 4158624.01
SYM011 GENITOURINARY SIGNS AND SYMPTOMS -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 219 2515308.25
SYM012 CIRCULATORY SIGNS AND SYMPTOMS -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 463 5598606.96
SYM013 RESPIRATORY SIGNS AND SYMPTOMS -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 766 10220063.04
SYM014 SKIN/SUBCUTANEOUS SIGNS AND SYMPTOMS -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 465 6160667.54
SYM015 GENERAL SENSATION/PERCEPTION SIGNS AND SYMPTOMS -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 298 3620887.01
SYM016 OTHER GENERAL SIGNS AND SYMPTOMS -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 984 11270520.47
SYM017 ABNORMAL FINDINGS WITHOUT DIAGNOSIS -1 INAPPLICABLE -1 INAPPLICABLE -1 INAPPLICABLE 553 7056125.99

83173 1078987415.99

Return To Table Of Contents

MEPS HOME . CONTACT MEPS . MEPS FAQ . MEPS SITE MAP . MEPS PRIVACY POLICY . ACCESSIBILITY . VIEWERS & PLAYERS . COPYRIGHT
Back to topGo back to top
Back to Top Go back to top

Connect With Us

Facebook Twitter You Tube LinkedIn

Sign up for Email Updates

To sign up for updates or to access your subscriber preferences, please enter your email address below.

Agency for Healthcare Research and Quality

5600 Fishers Lane
Rockville, MD 20857
Telephone: (301) 427-1364

  • Careers
  • Contact Us
  • Español
  • FAQs
  • Accessibility
  • Disclaimers
  • EEO
  • Electronic Policies
  • FOIA
  • HHS Digital Strategy
  • HHS Nondiscrimination Notice
  • Inspector General
  • Plain Writing Act
  • Privacy Policy
  • Viewers & Players
  • U.S. Department of Health & Human Services
  • The White House
  • USA.gov